Tokushima University / Educator and Researcher Directory --- Shimada, Kenji

Field of Study

Subject of Study

Book / Paper

Academic Paper (Judged Full Paper):

1.	Yasuhisa Kanematsu, Yuki Kanazawa, Kenji Shimada, Masaaki Korai, Takeshi Miyamoto, Shu Sogabe, Manabu Ishihara, Izumi Yamaguchi, Takeshi Oya, Nobuaki Yamamoto, Yuki Yamamoto, Miyoshi Mitsuharu, Masafumi Harada and Yasushi Takagi : Characterization of carotid plaques using chemical exchange saturation transfer imaging, Neuroradiology, Vol.66, No.9, 1617-1624, 2024. (Summary) The preoperative assessment of carotid plaques is necessary to render revascularization safe and effective. The aim of this study is to evaluate the usefulness of chemical exchange saturation transfer (CEST)-MRI, particularly amide proton transfer (APT) imaging as a preoperative carotid plaque diagnostic tool. We recorded the APT signal intensity on concentration maps of 34 patients scheduled for carotid endarterectomy. Plaques were categorized into group A (APT signal intensity ≥ 1.90 E-04; n = 12) and group B (APT signal intensity < 1.90 E-04; n = 22). Excised plaques were subjected to histopathological assessment and, using the classification promulgated by the American Heart Association, they were classified as intraplaque hemorrhage-positive [type VI-positive (tVI)] and -negative [no intraplaque hemorrhage (tVI)]. Of the 34 patients, 22 (64.7%) harbored tVI- and 12 (35.3%) had tVI plaques. The median APT signals were significantly higher in tVI- than tIVI patients (2.43 E-04 (IQR = 0.98-4.00 E-04) vs 0.54 E-04 (IQR = 0.14-1.09 E-04), p < .001). Histopathologically, the number of patients with tVI plaques was significantly greater in group A (100%, n = 12) than group B (45%, n = 22) (p < .01). The number of symptomatic patients or asymptomatic patients with worsening stenosis was also significantly greater in group A than group B (75% vs 36%, p < .01). In unstable plaques with intraplaque hemorrhage and in patients with symptoms or progressive stenosis, the ATP signals were significantly elevated. CEST-MRI studies has the potential for the preoperative assessment of the plaques' characteristics. (Keyword) Humans / Male / Female / Aged / Carotid Stenosis / Magnetic Resonance Imaging / Middle Aged / Endarterectomy, Carotid / Plaque, Atherosclerotic / Sensitivity and Specificity / Image Interpretation, Computer-Assisted (Link to Publication Site) ● Publication site (DOI): 10.1007/s00234-024-03401-3 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 38866959 ● Search Scopus @ Elsevier (PMID): 38866959 ● Search Scopus @ Elsevier (DOI): 10.1007/s00234-024-03401-3 (DOI: 10.1007/s00234-024-03401-3, PubMed: 38866959)
2.	Shu Sogabe, HABOSHI Tatsuya, Izumi Yamaguchi, Masaaki Korai, Nobuaki Yamamoto, Kenji Shimada, Yasuhisa Kanematsu and Yasushi Takagi : Experience of using coronary perfusion balloon catheter for acute middle cerebral artery occlusion, Surgical Neurology International, Vol.14, No.365, 365, 2023. (Summary) We present the case of an individual with acute occlusion of the middle cerebral artery caused by atherosclerosis. The patient underwent angioplasty using a coronary perfusion balloon, which resulted in a favorable clinical outcome. A 66-year-old male patient presented with an acute onset of right hemiplegia and dysarthria. Magnetic resonance imaging revealed an occlusion of the left middle cerebral artery, and alteplase was administered, followed by a mechanical thrombectomy and intracranial balloon catheter angioplasty. Due to restenosis, a coronary perfusion balloon catheter was used for a 15-minute angioplasty procedure while maintaining the perfusion. This treatment approach led to the recanalization of the artery and favorable clinical outcomes. The coronary perfusion balloon may represent a viable therapeutic alternative for the management of refractory intracranial atherosclerotic large vessel occlusion. (Tokushima University Institutional Repository) ● Metadata: 119408 (Link to Publication Site) ● Publication site (DOI): 10.25259/SNI_608_2023 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37941628 ● CiNii @ National Institute of Informatics (CRID): 1871146592942896128 ● Search Scopus @ Elsevier (PMID): 37941628 ● Search Scopus @ Elsevier (DOI): 10.25259/SNI_608_2023 (Tokushima University Institutional Repository: 119408, DOI: 10.25259/SNI_608_2023, PubMed: 37941628, CiNii: 1871146592942896128)
3.	Yuki Yamamoto, Nobuaki Yamamoto, Tomohiro Matsuda, Kazutaka Kuroda, Izumi Yamaguchi, Shu Sogabe, Masaaki Korai, Kenji Shimada, Yasuhisa Kanematsu, Yasushi Takagi and Yuishin Izumi : Stent retrieval for free-floating thrombus attached to carotid artery stenosis: A report of two cases., Surgical Neurology International, Vol.14, 274, 2023. (Summary) In cases of carotid artery stenosis with FFT, it is technically possible to retrieve a thrombus with a stent retriever. Although thrombus removal may help reduce the risk of ischemic complications in a series of urgent CAS procedures, there are concerns such as mechanical irritation to the carotid artery plaque, and its indications and alternative treatments should be carefully considered. (Tokushima University Institutional Repository) ● Metadata: 119409 (Link to Publication Site) ● Publication site (DOI): 10.25259/SNI_513_2023 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37680937 ● Search Scopus @ Elsevier (PMID): 37680937 ● Search Scopus @ Elsevier (DOI): 10.25259/SNI_513_2023 (Tokushima University Institutional Repository: 119409, DOI: 10.25259/SNI_513_2023, PubMed: 37680937)
4.	Nobuaki Yamamoto, Kazutaka Kuroda, Yuki Yamamoto, Izumi Yamaguchi, Shu Sogabe, Kenji Shimada, Ryoma Morigaki, Yasuhisa Kanematsu, Yuishin Izumi and Yasushi Takagi : Long-sheath Introducer-assisted Revascularization (L-SHARE) Technique for Treating Large-vessel Occlusion by a Giant Clot, Internal Medicine, Vol.62, No.6, 909-913, 2023. (Summary) Revascularization for common carotid artery (CCA) occlusion might be difficult. We reported our strategy for revascularizing CCA occlusion by giant clots. A 94-year-old woman was transferred to our hospital because of right hemiparesis and aphasia. CCA occlusion and giant clots were detected on ultrasonography. We performed mechanical thrombectomy using a 9-Fr balloon-guiding catheter, stent retriever, and aspiration catheter through a 9-Fr long-sheath introducer [long-sheath introducer-assisted revascularization (L-SHARE) technique]. We successfully recanalized CCA occlusion using this method. The L-SHARE technique might be useful for recanalization of CCA occlusion. (Keyword) mechanical thrombectomy / long-sheath introducer / giant clot / cerebral large-vessel occlusion (Tokushima University Institutional Repository) ● Metadata: 118794 (Link to Publication Site) ● Publication site (DOI): 10.2169/internalmedicine.0089-22 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35945008 ● CiNii @ National Institute of Informatics (CRID): 1390576900004177024 ● Search Scopus @ Elsevier (PMID): 35945008 ● Search Scopus @ Elsevier (DOI): 10.2169/internalmedicine.0089-22 (Tokushima University Institutional Repository: 118794, DOI: 10.2169/internalmedicine.0089-22, PubMed: 35945008, CiNii: 1390576900004177024)
5.	Manabu Ishihara, Yasuhisa Kanematsu, Nobuaki Yamamoto, Kenji Shimada, Takeshi Miyamoto, Izumi Yamaguchi, Shu Sogabe, Yuki Yamamoto, Jun Oto and Yasushi Takagi : Prognostic factors for acute large vessel occlusion with NIHSS 5 or lower., The Journal of Medical Investigation : JMI, Vol.70, No.1.2, 22-27, 2023. (Summary) MCA occlusion is associated with poor prognosis, even with NIHSS score ??5, and d-IAS may provide a predictor. J. Med. Invest. 70 : 22-27, February, 2023. (Keyword) Humans / Tissue Plasminogen Activator / Stroke / Prognosis / Retrospective Studies / Treatment Outcome (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.70.22 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37164724 ● Search Scopus @ Elsevier (PMID): 37164724 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.70.22 (DOI: 10.2152/jmi.70.22, PubMed: 37164724)
6.	Yasuhisa Kanematsu, Izumi Yamaguchi, Manabu Ishihara, Shu Sogabe, Takeshi Miyamoto, Masaaki Korai, Kenji Shimada, KURODA Kazutaka, Yuki Yamamoto, Nobuaki Yamamoto, Yuishin Izumi and Yasushi Takagi : 循環器病を防ぐために徳島県循環器病推進計画の中での急性期脳卒中診療の取り組み, Shikoku Acta Medica, Vol.78, No.5-6, 135-138, 2022. (Summary) Cerebrovascular and cardiovascular disease are the main causes of death in Japan. The leading causes of the need for long-term care in Japan are also cerebrovascular and cardiovascular disease, which together account for more than one-fourth of the total. The Cerebrovascular and Cardiovascular Disease Control Act, of Japanese national law, was promulgated by a legislative act in 2018. On the basis of the Cerebrovascular and Cardiovascular Disease Control Act, the Ministry of Health, Labour and Welfare, Japan, published the Japanese National Plan for Promotion of Measures Against Cerebrovascular and Cardiovascular Disease (Japanese National Plan) in 2020. By the example of the Japanese National Plan, Tokushima prefecture established a cerebrovascular and cardiovascular disease countermeasure promotion plan to progress cerebrovascular and cardiovascular disease measures according to their own circumstances. One of the important measures of the plan is improving emergency transportation systems. Patients with intracranial large vessel occlusion strokes should be served by direct transfer to endovascular capable centers avoiding delays by misguided transfer to primary stroke centers. Considering the limited availability of endovascular capable centers, accurate identification of patients with high probability of having large vessel occlusion strokes in the prehospital setting is importance. To address this problem, we introduced prehospital scale called Field Assessment Stroke Triage for Emergency Destination (FAST-ED) on emergency transportation systems in Tokushima city. (Keyword) Cerebrovascular and cardiovascular disease / emergency transportation systems / prehospital scale (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520858387633637376 (CiNii: 1520858387633637376)
7.	Yoshitaka Kurashiki, Hiroshi Kagusa, Kenji Yagi, Tomoya Kinouchi, Manabu Sumiyoshi, Takeshi Miyamoto, Kenji Shimada, Keiko T Kitazato, Yoshihiro Uto and Yasushi Takagi : Role of post-ischemic phase-dependent modulation of anti-inflammatory M2-type macrophages against rat brain damage, Journal of Cerebral Blood Flow and Metabolism, 2022. (Summary) Cerebral ischemia triggers inflammatory changes, and early complications and unfavorable outcomes of endovascular thrombectomy for brain occlusion promote the recruitment of various cell types to the ischemic area. Although anti-inflammatory M2-type macrophages are thought to exert protective effects against cerebral ischemia, little has been clarified regarding the significance of post-ischemic phase-dependent modulation of M2-type macrophages. To test our hypothesis that post-ischemic phase-dependent modulation of macrophages represents a potential therapy against ischemic brain damage, the effects on rats of an M2-type macrophage-specific activator, Gc-protein macrophage-activating factor (GcMAF), were compared with vehicle-treated control rats in the acute (day 0-6) or subacute (day 7-13) phase after ischemia induction. Acute-phase GcMAF treatment augmented both anti-inflammatory CD163 M2-type- and pro-inflammatory CD16 M1-type macrophages, resulting in no beneficial effects. Conversely, subacute-phase GcMAF injection increased only CD163 M2-type macrophages accompanied by elevated mRNA levels of arginase-1 and interleukin-4. M2-type macrophages co-localized with CD36 phagocytic cells led to clearance of the infarct area, which were abrogated by clodronate-liposomes. Expression of survival-related molecules on day 28 at the infarct border was augmented by GcMAF. These data provide new and important insights into the significance of M2-type macrophage-specific activation as post-ischemic phase-dependent therapy. (Tokushima University Institutional Repository) ● Metadata: 118878 (Link to Publication Site) ● Publication site (DOI): 10.1177/0271678X221147090 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 36545833 ● Summary page in Scopus @ Elsevier: 2-s2.0-85145451559 (Tokushima University Institutional Repository: 118878, DOI: 10.1177/0271678X221147090, PubMed: 36545833, Elsevier: Scopus)
8.	KURODA Kazutaka, Yuki Yamamoto, Nobuaki Yamamoto, Yuishin Izumi, Izumi Yamaguchi, Kenji Shimada, Yasuhisa Kanematsu, Takeshi Miyamoto and Yasushi Takagi : 脳静脈洞血栓症に対して経皮的血栓回収術を行った3例, Shikoku Acta Medica, Vol.78, No.5-6, 221-226, 2022.
9.	Yuki Yamamoto, Nobuaki Yamamoto, KURODA Kazutaka, Yuishin Izumi, Yasuhisa Kanematsu, Izumi Yamaguchi, Shu Sogabe, Masaaki Korai, Kenji Shimada and Yasushi Takagi : 徳島市におけるアプリケーションを用いた脳主幹動脈閉塞診断スケールの活用,, Shikoku Acta Medica, Vol.78, No.5,6, 248-249, 2022.
10.	Kenji Shimada, Kazuhisa Miyake, Izumi Yamaguchi, Shu Sogabe, Masaaki Korai, Yasuhisa Kanematsu and Yasushi Takagi : Efficacy of Utilizing Both 3-Dimensional Multimodal Fusion Image and Intra-Arterial Indocyanine Green Videoangiography in Cerebral Arteriovenous Malformation Surgery, World Neurosurgery, Vol.169, e260-e269, 2022. (Summary) An understanding of the complex morphology of an arteriovenous malformation (AVM) is important for successful resection. We have previously reported the utility of intra-arterial indocyanine green (ICG) videoangiography for this purpose, but that method cannot detect the angioarchitecture covered by brain tissue. 3-dimensional (3D) multimodal fusion imaging is reportedly useful for this same purpose, but cannot always visualize the exact angioarchitecture due to poor source images and processing techniques. This study examined the results of utilizing both techniques in patients with AVMs. Both techniques were applied in 12 patients with AVMs. Both images were compared with surgical views and evaluated by surgeons. Although evaluations for identifying superficial feeders by ICG videoangiography were high in all cases, the more complicated the AVM, the lower the evaluation by 3D multimodal fusion imaging. Conversely, evaluation of the estimated range of the nidus was high in all cases by 3D multimodal fusion imaging, but low in all but one case by ICG videoangiography. Nidus flow reduction was recognized by Flow 800 analysis obtained after ICG videoangiography. These results showed that utilizing both techniques together was more useful than each modality alone in AVM surgery. This was particularly effective in identifying superficial feeders and estimating the range of the nidus. This technique is expected to offer an optimal tool for AVM surgery. (Tokushima University Institutional Repository) ● Metadata: 118079 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.wneu.2022.10.121 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 36332776 ● Search Scopus @ Elsevier (PMID): 36332776 ● Search Scopus @ Elsevier (DOI): 10.1016/j.wneu.2022.10.121 (Tokushima University Institutional Repository: 118079, DOI: 10.1016/j.wneu.2022.10.121, PubMed: 36332776)
11.	Eiji Shikata, Takeshi Miyamoto, Tadashi Yamaguchi, Izumi Yamaguchi, Hiroshi Kagusa, Daiki Gotoh, Kenji Shimada, Yoshiteru Tada, Kenji Yagi, 北里慶子, Yasuhisa Kanematsu and Yasushi Takagi : An imbalance between RAGE/MR/HMGB1 and ATP1α3 is associated with infammatory changes in rat brain harboring cerebral aneurysms prone to rupture, Journal of Neuroinflammation, Vol.19, No.161, 161, 2022. (Summary) An aneurysmal subarachnoid hemorrhage is a devastating event. To establish an effective therapeutic strategy, its pathogenesis must be clarified, particularly the pathophysiology of brain harboring intracranial aneurysms (IAs). To elucidate the pathology in brain harboring IAs, we examined the significance of the receptor for advanced glycation end-products (RAGE)/mineralocorticoid receptor (MR) pathway and Na/K-ATPase (ATP1α3). Ten-week-old female rats were subjected to oophorectomy as well as hypertension and hemodynamic changes to induce IAs, and were fed a high-salt diet. Brain damage in these rats was assessed by inflammatory changes in comparison to sham-operated rats fed a standard diet. Six weeks after IA induction (n = 30), irregular morphological changes, i.e., an enlarged vessel diameter and vascular wall, were observed in all of the left posterior cerebral arteries (Lt PCAs) prone to rupture. Approximately 20% of rats had ruptured IAs within 6 weeks. In brain harboring unruptured IAs at the PCA, the mRNA levels of RAGE and MR were higher, and that of ATP1α3 was lower than those in the sham-operated rats (p < 0.05, each). Immunohistochemically, elevated expression of RAGE and MR, and decreased expression of ATP1α3 were observed in the brain parenchyma adjacent to the Lt PCA, resulting in increased Iba-1 and S100B expression that reflected the inflammatory changes. There was no difference between the unruptured and ruptured aneurysm rat groups. Treatment with the MR antagonist esaxerenone abrogated these changes, and led to cerebral and vascular normalization and prolonged subarachnoid hemorrhage-free survival (p < 0.05). Regulation of the imbalance between the RAGE/MR pathway and ATP1α3 may help attenuate the damage in brain harboring IAs, and further studies are warranted to clarify the significance of the down-regulation of the MR/RAGE pathway and the up-regulation of ATP1α3 for attenuating the pathological changes in brain harboring IAs. (Keyword) Aneurysm, Ruptured / Animals / Brain / Female / HMGB1 Protein / Intracranial Aneurysm / Rats / Receptor for Advanced Glycation End Products / Receptors, Mineralocorticoid / Sodium-Potassium-Exchanging ATPase / Subarachnoid Hemorrhage (Tokushima University Institutional Repository) ● Metadata: 117703 (Link to Publication Site) ● Publication site (DOI): 10.1186/s12974-022-02526-7 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35725479 ● Search Scopus @ Elsevier (PMID): 35725479 ● Search Scopus @ Elsevier (DOI): 10.1186/s12974-022-02526-7 (Tokushima University Institutional Repository: 117703, DOI: 10.1186/s12974-022-02526-7, PubMed: 35725479)
12.	Kenji Shimada, Izumi Yamaguchi, Takeshi Miyamoto, Shu Sogabe, Kazuhisa Miyake, Yasuhisa Kanematsu and Yasushi Takagi : Efficacy of intraarterial indocyanine green videoangiography in surgery for arteriovenous fistula at the craniocervical junction in a hybrid operating room: illustrative cases, Journal of Neurosurgery. Case Lessons, Vol.3, No.23, 1-6, 2022. (Summary) Sufficient understanding of the angioarchitecture of an arteriovenous fistula (AVF) at the craniocervical junction (CCJ) is crucial to surgical treatment but is often difficult because of the complex vascular anatomy. Intraarterial indocyanine green (ICG) videoangiography has emerged as a more useful option for understanding the vascular anatomy than intravenous ICG videoangiography. This report describes two cases of CCJ AVFs successfully treated by surgery using intraarterial ICG videoangiography and describes the efficacy of this technique. Case 1 involved a 71-year-old man presenting with tetraparesis after sudden onset of severe headache due to subarachnoid hemorrhage (SAH). Digital subtraction angiography (DSA) demonstrated CCJ epidural AVF. Intraarterial ICG videoangiography revealed the drainer, which had been difficult to identify. The AVF disappeared after disconnection of the drainer. Case 2 involved a 68-year-old man presenting with severe headache due to SAH. DSA showed multiple AVFs at the CCJ and cerebellar tentorium. Intraarterial ICG videoangiography demonstrated concomitant perimedullary AVF and dural AVF at the CCJ. All AVFs disappeared postoperatively. Intraarterial ICG videoangiography was useful for definitive diagnosis of CCJ AVF, facilitating identification of feeders and drainers with bright and high phase contrast and allowing repeated testing to confirm flow direction. (Link to Publication Site) ● Publication site (DOI): 10.3171/CASE22100 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35733826 ● Search Scopus @ Elsevier (PMID): 35733826 ● Search Scopus @ Elsevier (DOI): 10.3171/CASE22100 (DOI: 10.3171/CASE22100, PubMed: 35733826)
13.	Izumi Yamaguchi, Yasuhisa Kanematsu, Kenji Shimada, Nobuaki Yamamoto, Kazuhisa Miyake, Takeshi Miyamoto, Shu Sogabe, Eiji Shikata, Manabu Ishihara, 山本陽子, Kazutaka Kuroda and Yasushi Takagi : Single-session hematoma removal and transcortical venous approach for coil embolization of an isolated transverse-sigmoid sinus dural arteriovenous fistula in a hybrid operating room: illustrative case, Journal of Neurosurgery. Case Lessons, Vol.3, No.21, CASE2267, 2022. (Summary) Dural arteriovenous fistula (DAVF) can present with massive hematoma, which sometimes requires emergent removal. Therefore, a surgical strategy for single-session hematoma removal and shunt occlusion in the same surgical field is important. A 73-year-old man was transferred to the authors' hospital with a headache. Brain computed tomography (CT) revealed an intracerebral hematoma in the right temporoparietal lobe (hematoma volume 12 ml). A cerebral angiogram revealed a right isolated transverse-sigmoid sinus (TSS)-DAVF fed by the occipital artery and middle meningeal artery. There was cortical venous reflux into the Labbé vein and posterior parietal vein. Percutaneous transarterial and transvenous embolization were unsuccessful. The following day, his consciousness level acutely declined with a headache, and brain CT showed hematoma expansion (hematoma volume 41 ml) with a midline shift. Therefore, the authors performed single-session hematoma removal and a transcortical venous approach for coil embolization of an isolated TSS-DAVF in a hybrid operating room. His postoperative course was uneventful. No recurrence was observed 3 months postoperatively on cerebral angiography. Single-session hematoma removal and a transcortical venous approach for coil embolization of an isolated TSS-DAVF is considered in cases with massive hematoma. This strategy is useful, considering recent developments in hybrid operating rooms. (Link to Publication Site) ● Publication site (DOI): 10.3171/CASE2267 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35734231 ● Summary page in Scopus @ Elsevier: 2-s2.0-85160834258 (DOI: 10.3171/CASE2267, PubMed: 35734231, Elsevier: Scopus)
14.	Tadashi Yamaguchi, Takeshi Miyamoto, Eiji Shikata, Izumi Yamaguchi, Kenji Shimada, Kenji Yagi, Yoshiteru Tada, Masaaki Korai, Keiko T. Kitazato, Yasuhisa Kanematsu and Yasushi Takagi : Activation of the NLRP3/IL-1β/MMP-9 pathway and intracranial aneurysm rupture associated with the depletion of ERα and Sirt1 in oophorectomized rats, Journal of Neurosurgery, 1-8, 2022. (Summary) Subarachnoid hemorrhage (SAH) due to intracranial aneurysm (IA) rupture is often a devastating event. Since the incidence of SAH increases especially in menopause, it is crucial to clarify the detailed pathogenesis of these events. The activation of vascular nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasomes has been studied in ischemic stroke and cardiovascular disease. However, the role of NLRP3 in IA rupture still needs to be explained. The authors sought to test their hypothesis that, under estrogen-deficient conditions, activation of NLRP3 inflammasomes via downregulation of the estrogen receptor (ER) facilitates IA rupture. Ten-week-old female Sprague Dawley rats with and without oophorectomy were subjected to hemodynamic changes and hypertension (OVX+/HT and OVX-/HT, respectively) and fed a high-salt diet. Separately, using human brain endothelial cells (HBECs) and human brain smooth muscle cells (HBSMCs), the authors tested the effect of NLRP3 under estrogen-free conditions and in the presence of estradiol or of ER agonists. In OVX+/HT rats, the frequency of IA rupture was significantly higher than in OVX-/HT rats (p = 0.03). In the left posterior cerebral artery prone to rupture in OVX+/HT rats, the levels of the mRNAs encoding ERα and Sirt1, but not of that encoding ERβ, were decreased, and the levels of the mRNAs encoding NLRP3, interleukin-1β (IL-1β), and matrix metalloproteinase 9 (MMP-9) were elevated. Immunohistochemical analysis demonstrated that the expression profiles of these proteins correlated with their mRNA levels. Treatment with an ER modulator, bazedoxifene, normalized the expression profiles of these proteins and improved SAH-free survival. In HBECs and HBSMCs under estrogen-free conditions, the depletion of ERα and Sirt1 and the accumulation of NLRP3 were counteracted by exposure to estradiol or to an ERα agonist but not to an ERβ agonist. To the authors' knowledge, this work represents the first demonstration that, in an aneurysm model under estrogen-deficient conditions, the depletion of ERα and Sirt1 may contribute to activation of the NLRP3/IL-1β/MMP-9 pathway, facilitating the rupture of IAs in the estrogen-deficient rat IA rupture model. (Tokushima University Institutional Repository) ● Metadata: 117700 (Link to Publication Site) ● Publication site (DOI): 10.3171/2022.4.JNS212945 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35594890 ● Search Scopus @ Elsevier (PMID): 35594890 ● Search Scopus @ Elsevier (DOI): 10.3171/2022.4.JNS212945 (Tokushima University Institutional Repository: 117700, DOI: 10.3171/2022.4.JNS212945, PubMed: 35594890)
15.	Eiji Shikata, Izumi Yamaguchi, Masaaki Korai, Takeshi Miyamoto, Tadashi Yamaguchi, Hiroshi Kagusa, Kenji Shimada, Yoshiteru Tada, Keiko Kitazato, Yasuhisa Kanematsu and Yasushi Takagi : Could clazosentan, first approved in Japan, improve neurological prognosis after subarachnoid hemorrhage in combination with modified water-electrolyte management?, Brain Hemorrhages, Vol.137, No.6, 1707-1717, 2022. (Tokushima University Institutional Repository) ● Metadata: 118951 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.hest.2023.10.005 (Link to Search Site for Scientific Articles) ● Summary page in Scopus @ Elsevier: 2-s2.0-85175417356 (Tokushima University Institutional Repository: 118951, DOI: 10.1016/j.hest.2023.10.005, Elsevier: Scopus)
16.	Yoshiteru Tada, Toshitaka Fujihara, Kenji Shimada, Nobuaki Yamamoto, Hiroki Yamazaki, Yuishin Izumi, Masafumi Harada, Yasuhisa Kanematsu and Yasushi Takagi : Seizure types associated with negative arterial spin labeling and positive diffusion-weighted imaging on peri-ictal magnetic resonance imaging, Journal of the Neurological Sciences, Vol.436, 1-8, 2022. (Summary) Arterial spin labeling (ASL) and diffusion-weighted imaging (DWI) are useful for assessing hyperperfusion and cytotoxic edema, respectively, caused by acute seizures. This study investigated the clinical characteristics associated with normal ASL findings and DWI abnormalities in patients with acute seizures. Overall, 41 patients with ASL and DWI images that were obtained within 48 h of focal onset seizure diagnosis, due to epilepsy or acute symptomatic seizures, were divided into groups based on initial ASL findings (ASL-negative vs. ASL-positive), and DWI abnormalities (DWI-negative vs. DWI-positive). The diagnosis was made based on seizure semiology, electroencephalography, and conventional imaging modalities. ASL and DWI abnormalities were based on visual assessment. Of the 41 patients, eight (19.5%) displayed normal ASL findings. The proportion of patients with focal aware seizures (FAS) was significantly higher among ASL-negative patients (62.5%) than that in ASL-positive patients (15.2%); the proportion of patients with focal impaired awareness seizures (FIAS) was significantly lower among ASL-negative patients (12.5%) than that among ASL-positive patients (57.6%). Hyperintensity findings on DWI were observed in 12 patients (29.3%, DWI-positive). The proportion of patients with FIAS was significantly higher among DWI-positive patients (75.0%) than that among DWI-negative patients (37.9%). Multivariate analysis revealed that FAS and FIAS were associated with normal ASL findings (odds ratio [OR]: 21.37, P = 0.010) and DWI abnormalities (OR = 6.11, P = 0.028). A diagnosis of seizures should not be excluded based on normal ASL findings, especially in patients with FAS. FIAS may be a risk factor for neuronal damage caused by seizure activity. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jns.2022.120223 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35279594 ● Summary page in Scopus @ Elsevier: 2-s2.0-85126008460 (DOI: 10.1016/j.jns.2022.120223, PubMed: 35279594, Elsevier: Scopus)
17.	Yuki Yamamoto, Nobuaki Yamamoto, Yasuhisa Kanematsu, Izumi Yamaguchi, Manabu Ishihara, Takeshi Miyamoto, Shu Sogabe, Kenji Shimada, Yasushi Takagi and Yuishin Izumi : The claw sign predicts first-pass effect in mechanical thrombectomy for cerebral large vessel occlusion in the anterior circulation, Surgical Neurology International, Vol.13, No.72, 1-7, 2022. (Summary) Mechanical thrombectomy (MT) is an effective treatment for acute cerebral large vessel occlusion (LVO). Complete recanalization of vessels in a single procedure is defined as the first-pass effect (FPE) and is associated with good prognosis. In this study, angiographic clot protruding sign termed the "claw sign," was examined as candidate preoperative imaging factor for predicting the FPE. We retrospectively analyzed data from 91 consecutive patients treated for acute LVO in the anterior circulation by MT between January 2014 and December 2019. The claw sign was defined as a thrombus that protruded proximally by more than half of the diameter of the parent artery. Radiological findings such as claw sign, clinical and etiological features, and outcomes were compared between groups with and without successful FPE. Multivariate analysis was conducted to evaluate perioperative factors associated with FPE. FPE was achieved in 26 of 91 (28.6%) patients and the claw sign was observed in 34 of 91 (37.4%) patients. The claw sign was significantly more frequent in the successful FPE group than in the failed FPE group (53.8% vs. 30.8%; = 0.040). After the multivariate analysis, the claw sign was the only pretreatment parameter that could predict FPE (odds ratio, 2.67; 95% confidence interval, 1.01-7.06; = 0.047). The claw sign is an angiographic imaging factor that might predict FPE after MT for anterior circulation acute ischemic stroke. (Tokushima University Institutional Repository) ● Metadata: 117192 (Link to Publication Site) ● Publication site (DOI): 10.25259/SNI_1160_2021 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35242438 ● Search Scopus @ Elsevier (PMID): 35242438 ● Search Scopus @ Elsevier (DOI): 10.25259/SNI_1160_2021 (Tokushima University Institutional Repository: 117192, DOI: 10.25259/SNI_1160_2021, PubMed: 35242438)
18.	Kenya Kusunose, Hironori Takahashi, Susumu Nishio, Yukina Hirata, Robert Zheng, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Kenji Shimada, Yasuhisa Kanematsu, Yasushi Takagi and Masataka Sata : Predictive value of left atrial function for latent paroxysmal atrial fibrillation as the cause of embolic stroke of undetermined source, Journal of Cardiology, Vol.78, No.5, 355-361, 2021. (Summary) In patients with embolic stroke of undetermined source (ESUS), paroxysmal atrial fibrillation (AF) is often diagnosed, however, the risk of paroxysmal AF in ESUS has not been well described. Several studies have suggested a linkage between left atrial (LA) functional parameters and risk of AF in stroke patients. The aim of this study was to assess the role of LA functional parameters as predictors of latent paroxysmal AF in ESUS on admission. Between January 2015 and December 2019, consecutive stroke patients with suspected ESUS at admission were prospectively included in this study. They were under hospital electrocardiographic monitoring for detection of new-onset AF. Various echocardiographic parameters including left atrial strain were assessed for association with new-onset AF. We gathered 1082 consecutive patients with ischemic stroke. After exclusions, 121 patients with suspected ESUS at admission formed the study cohort. New-onset AF was detected in 46 (38%) patients during hospital electrocardiographic monitoring (median follow-up: 18 days). LA pump and reservoir strains were significantly and independently associated with new-onset AF. Receiver operating characteristic analysis for the association with new-onset AF showed that the areas under the curve (AUCs) of clinical parameters plus one of each strain (LA pump strain: AUC: 0.86±0.04 and LA reservoir strain: AUC: 0.76±0.05) models were significantly better than plus LA volume index (AUC: 0.68±0.04, compared p-values <0.05). LA strain was significantly associated with new development of AF. Patients with impaired LA function at admission should be carefully monitored to find AF. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jjcc.2021.05.005 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34119401 ● Search Scopus @ Elsevier (PMID): 34119401 ● Search Scopus @ Elsevier (DOI): 10.1016/j.jjcc.2021.05.005 (DOI: 10.1016/j.jjcc.2021.05.005, PubMed: 34119401)
19.	Kenji Shimada, Izumi Yamaguchi, Manabu Ishihara, Takeshi Miyamoto, Shu Sogabe, Kazuhisa Miyake, Yoshiteru Tada, 北里慶子, Yasuhisa Kanematsu and Yasushi Takagi : Involvement of Neutrophil Extracellular Traps in Cerebral Arteriovenous Malformations, World Neurosurgery, E1-E7, 2021. (Summary) Cerebral arteriovenous malformations (cAVMs) represent tangles of abnormal vasculature without intervening capillaries. High-pressure vascular channels due to abnormal arterial and venous shunts can lead to rupture. Multiple pathways are involved in the pathobiology of cAVMs including inflammation and genetic factors such as KRAS mutations. Neutrophil release of nuclear chromatin, known as neutrophil extracellular traps (NETs), plays a multifunctional role in infection, inflammation, thrombosis, intracranial aneurysms, and tumor progression. However, the relationship between NETs and the pathobiology of cAVMs remains unknown. We tested whether NETs play a role in the pathobiology of cAVMs. We analyzed samples from patients who had undergone surgery for cAVM and immunohistochemically investigated expression of citrullinated histone H3 (CitH3) as a marker of NETs. CitH3 expression was compared among samples from cAVM patients, epilepsy patients, and normal human brain tissue. Expressions of thrombotic and inflammatory markers were also examined immunohistochemically in samples from cAVM patients. Expression of CitH3 derived from neutrophils was observed intravascularly in all cAVM samples but not other samples. Nidi of AVMs showed migration of many Iba-I-positive cells adjacent to the endothelium and endothelial COX2 expression, accompanied by expression of IL-6 and IL-8 in the endothelium and intravascular neutrophils. Unexpectedly, expression of CitH3 was not necessarily localized to the vascular wall and thrombus. Our results offer the first evidence of intravascular expression of NETs, which might be associated with vascular inflammation in cAVMs. (Tokushima University Institutional Repository) ● Metadata: 116871 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.wneu.2021.08.118 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34478890 ● Summary page in Scopus @ Elsevier: 2-s2.0-85115331132 (Tokushima University Institutional Repository: 116871, DOI: 10.1016/j.wneu.2021.08.118, PubMed: 34478890, Elsevier: Scopus)
20.	Masaaki Korai, Yasuhisa Kanematsu, Izumi Yamaguchi, Tadashi Yamaguchi, Yuki Yamamoto, Nobuaki Yamamoto, Takeshi Miyamoto, Kenji Shimada, Junichiro Satomi, Mami Hanaoka, Kazuhito Matsuzaki, Koichi Satoh and Yasushi Takagi : Subarachnoid Hemorrhage Due to Rupture of Vertebral Artery Dissecting Aneurysms: Treatments, Outcomes, and Prognostic Factors, World Neurosurgery, Vol.152, e86-e93, 2021. (Summary) Mortality rate after subarachnoid hemorrhage due to rupture of vertebral artery dissecting aneurysms (VADAs) is high; endovascular coil trapping is the first-line therapy to prevent rerupture. To select optimal treatments, the positional relationship between the VADA and posterior inferior cerebellar artery (PICA) and the morphology of the contralateral vertebral artery must be considered, and outcome predictors of different treatment methods and their possible complications must be identified. We retrospectively studied 44 patients with ruptured VADAs who had undergone endovascular or surgical treatment. VADA morphology was assessed on conventional preoperative angiograms, and VADAs were categorized based on their site in relation to the PICA. VADA site, treatment method, and complications were used to identify prognostic factors. The sites of the 44 VADAs were PICA-proximal (n = 3), PICA-distal (n = 22), PICA-absent (n = 7), and PICA-involved (n = 12). Treatments included internal coil trapping (n = 30), proximal coil occlusion (n = 5), and stent placement (n = 3); surgical flow alteration via an occipital artery-PICA bypass and ligation at the proximal vertebral artery and the PICA origin was performed in 6 patients. Periprocedural rebleeding was associated with a poor outcome. Internal coil trapping prevented the rerupture of PICA-proximal and PICA-absent VADAs, and flow alteration prevented rerupture of PICA-involved VADAs; there were no complications directly attributable to these procedures. Periprocedural rebleeding was a poor prognostic factor. Internal trapping of PICA-proximal and PICA-absent VADAs and flow alteration in PICA-involved VADAs prevented rerupture. (Keyword) Adult / Aged / Aged, 80 and over / Aneurysm, Ruptured / Follow-Up Studies / Humans / Male / Middle Aged / Prognosis / Retrospective Studies / Subarachnoid Hemorrhage / Treatment Outcome / Vertebral Artery Dissection (Link to Publication Site) ● Publication site (DOI): 10.1016/j.wneu.2021.05.018 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34051365 ● Search Scopus @ Elsevier (PMID): 34051365 ● Search Scopus @ Elsevier (DOI): 10.1016/j.wneu.2021.05.018 (DOI: 10.1016/j.wneu.2021.05.018, PubMed: 34051365)
21.	Yasuhisa Kanematsu, Kenji Shimada, Yoshiteru Tada, Masaaki Korai, Takeshi Miyamoto, Shu Sogabe, Izumi Yamaguchi, Yoko Ymamoto, Nobuaki Yamamoto, Yuki Yamamoto, Koichi Satoh and Yasushi Takagi : Coil embolization with overlapping horizontal low-profile stents to treat a giant thrombosed fetal posterior cerebral aneurysm using contralateral approach through anterior communicating artery: Case report., Surgical Neurology International, Vol.12, No.347, 2021. (Summary) The treatment of internal carotid artery (ICA) - posterior communicating artery aneurysms (ICPC aneurysms) is challenging when a fetal posterior cerebral artery (PCA) arises from the saccular neck. This complex angioarchitecture renders endovascular approaches difficult. Giant thrombosed IC-PC aneurysms are also hard to treat by endovascular coiling because its flow-diversion effect is insufficient. We report the first case of a ruptured giant thrombosed IC-PC aneurysm associated with a fetal PCA that was successfully treated by coil embolization with retrograde overlap horizontal stenting using low-profile stents introduced through the contralateral ICA. The aneurysm was completely occluded and follow-up MRI scans demonstrated the reduction of the aneurysmal size. Our technique is advantageous because low-profile stents can be used to treat lesions not accessible with flow-diverter stents due their presence in complex angioarchitectures, and overlap stenting may have flow-diversion effects that can result in the complete occlusion of giant thrombosed aneurysms. (Tokushima University Institutional Repository) ● Metadata: 119411 (Link to Publication Site) ● Publication site (DOI): 10.25259/SNI_533_2021 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34345487 ● Search Scopus @ Elsevier (PMID): 34345487 ● Search Scopus @ Elsevier (DOI): 10.25259/SNI_533_2021 (Tokushima University Institutional Repository: 119411, DOI: 10.25259/SNI_533_2021, PubMed: 34345487)
22.	Pham Tran Phuong, Daiju Fukuda, Sachiko Nishimoto, JR Kim-Kaneyama, XF Lei, Yutaka Takahashi, Tomohito Sato, Kimie Tanaka, Kumiko Suto, Yutaka Kawabata, Koji Yamaguchi, Shusuke Yagi, Kenya Kusunose, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Kenji Shimada, Yasuhisa Kanematsu, Yasushi Takagi, Michio Shimabukuro, Mitsutoshi Setou, Glen N Barber and Masataka Sata : STING, a cytosolic DNA sensor, plays a critical role in atherogenesis: a link between innate immunity and chronic inflammation caused by lifestyle-related diseases, European Heart Journal, Vol.42, No.42, 4336-4348, 2021. (Summary) Lifestyle-related diseases promote atherosclerosis, a chronic inflammatory disease; however, the molecular mechanism remains largely unknown. Endogenous DNA fragments released under over-nutrient condition provoke sterile inflammation through the recognition by DNA sensors. Here, we investigated the role of stimulator of interferon genes (STING), a cytosolic DNA sensor, in atherogenesis. Apolipoprotein E-deficient (Apoe-/-) mice fed a western-type diet (WTD), a hypercholesterolaemic mouse model, showed higher STING expression and markers for DNA damage such as γH2AX, p53, and single-stranded DNA (ssDNA) accumulation in macrophages in the aorta compared with wild-type (WT) mice. The level of cGAMP, a STING agonist, in the aorta was higher in Apoe-/- mice. Genetic deletion of Sting in Apoe-/- mice reduced atherosclerotic lesions in the aortic arch, lipid, and macrophage accumulation in plaques, and inflammatory molecule expression in the aorta compared with the control. Pharmacological blockade of STING using a specific inhibitor, C-176, ameliorated atherogenesis in Apoe-/- mice. In contrast, bone marrow-specific STING expression in Apoe-/- mice stimulated atherogenesis. Expression or deletion of STING did not affect metabolic parameters and blood pressure. In vitro studies revealed that STING activation by cGAMP or mitochondrial DNA accelerated inflammatory molecule expression (e.g. TNF-α or IFN-β) in mouse and human macrophages. Activation of nuclear factor-κB and TANK binding kinase 1 was involved in STING-associated vascular inflammation and macrophage activation. Furthermore, human atherosclerotic lesions in the carotid arteries expressed STING and cGAMP. Stimulator of interferon genes stimulates pro-inflammatory activation of macrophages, leading to the development of atherosclerosis. Stimulator of interferon genes signalling may serve as a potential therapeutic target for atherosclerosis. (Link to Publication Site) ● Publication site (DOI): 10.1093/eurheartj/ehab249 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34226923 ● Summary page in Scopus @ Elsevier: 2-s2.0-85120384111 (DOI: 10.1093/eurheartj/ehab249, PubMed: 34226923, Elsevier: Scopus)
23.	Kenji Shimada, Yoko Yamamoto, Takeshi Miyamoto, Shu Sogabe, Toshitaka Fujihara, Kohhei Nakajima, Yoshifumi Mizobuchi, Yasuhisa Kanematsu and Yasushi Takagi : Efficacy of Intra-arterial Indocyanine Green Videoangiography in Hemangioblastoma Surgery: A Case Report., NMC Case Report Journal, Vol.8, No.1, 295-300, 2021. (Summary) Intravenous indocyanine green (ICG) videoangiography is reportedly useful for vascular neurosurgery, and for treating hemangioblastoma due to its high vascularity. Videoangiography obtained after intra-arterial ICG injection has emerged as a more useful option than that after intravenous injection. This report offers the first description of a case of hemangioblastoma successfully treated using intra-arterial ICG videoangiography, and describes the efficacy of this technique. A 20-year-old man presented with progressive cerebellar ataxia and dysphagia. Magnetic resonance imaging (MRI) revealed an enhanced solid tumor in the medulla oblongata. Digital subtraction angiography (DSA) showed a highly vascularized tumor. Surgery was performed to remove the tumor in a hybrid operating room. A catheter was introduced into the vertebral artery (VA) for intra-arterial ICG videoangiography. Superficial feeders and drainers were identified and flow dynamic changes in the tumor were assessed by intra-arterial ICG videoangiography. The tumor was removed after confirming lack of flow in the drainer. Intra-arterial ICG videoangiography was more useful than intravenous ICG videoangiography in hemangioblastoma surgery for identifying feeders and drainers and assessing flow dynamics in the tumor. Use of Flow 800 made these findings simpler and easier to evaluate. (Link to Publication Site) ● Publication site (DOI): 10.2176/nmccrj.cr.2020-0281 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35079478 ● Search Scopus @ Elsevier (PMID): 35079478 ● Search Scopus @ Elsevier (DOI): 10.2176/nmccrj.cr.2020-0281 (DOI: 10.2176/nmccrj.cr.2020-0281, PubMed: 35079478)
24.	Nobuaki Yamamoto, Yuki Yamamoto, Izumi Yamaguchi, Shu Sogabe, Takeshi Miyamoto, Kenji Shimada, Yasuhisa Kanematsu, Ryoma Morigaki, Yuishin Izumi and Yasushi Takagi : Percutaneous Transluminal Angioplasty and Stenting Using an Aspiration Catheter, Journal of Neuroendovascular Therapy, Vol.16, No.5, 277-282, 2021. (Summary) <p><b>Objective</b>: During percutaneous transluminal angioplasty (PTA) for the vertebral artery, occlusion of the subclavian artery using a balloon guiding catheter may be useful to prevent embolism of clots and/or debris distal to an atherosclerotic lesion. However, when placing a balloon guiding catheter at the intended vessels is difficult, it may be useful to use an aspiration catheter (AC) for mechanical thrombectomy as an intermediate catheter to suction way clots and/or debris. We report two cases in which PTA was performed for an atherosclerotic lesion at the intracranial vertebral artery using an AC, which ended without complications.</p><p><b>Case Presentations</b>: Case 1: A 74-year-old man presented with dysarthria and was admitted to our hospital. MRI revealed severe left vertebral artery stenosis and diffuse cerebral infarct areas at the territory of the posterior circulation. The patient had an abdominal aortic aneurysm and abnormally shaped left tortuous subclavian artery. Therefore, we performed PTA and stenting via the left brachial artery. We guided a 6-Fr long sheath to the left subclavian artery, and a 6-Fr AC for thrombectomy was guided through the long sheath to the V4 portion of the left vertebral artery. Thereafter, PTA was carried out under manual aspiration from the AC. As restenosis at the atherosclerotic lesion occurred after PTA, we performed stenting using a coronary stent system for this lesion under manual aspiration from the AC. No new infarct areas were observed on post-procedural MRI. Case 2: A 74-year-old woman presented with dysarthria and was admitted to our hospital. MRI demonstrated basilar artery occlusion and diffuse cerebral infarct areas at the territory of the posterior circulation. As her symptom worsened after admission, we performed urgent mechanical thrombectomy. We first performed thrombectomy using a stent retriever and then performed PTA and stenting (PTAS) for residual basilar artery stenosis via the AC under manual aspiration.</p><p><b>Conclusion</b>: When it is difficult to place a guiding catheter at the intended vessels during PTA, an AC may be useful to prevent distal embolization.</p> (Keyword) percutaneous transluminal angioplasty / aspiration catheter (Link to Publication Site) ● Publication site (DOI): 10.5797/jnet.cr.2021-0030 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390573593425698304 ● Search Scopus @ Elsevier (DOI): 10.5797/jnet.cr.2021-0030 (DOI: 10.5797/jnet.cr.2021-0030, CiNii: 1390573593425698304)
25.	Izumi Yamaguchi, Yasuhisa Kanematsu, Kenji Shimada, Kohhei Nakajima, Takeshi Miyamoto, Shu Sogabe, Eiji Shikata, Manabu Ishihara, Mai Azumi, Ayato Kageyama and Yasushi Takagi : Gelatinthrombin Hemostatic Matrix-related Cyst Formation after Cerebral Hematoma Evacuation: A Report of Two Cases, NMC Case Report Journal, Vol.8, No.1, 719-725, 2021. (Link to Publication Site) ● Publication site (DOI): 10.2176/nmccrj.cr.2021-0130 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.2176/nmccrj.cr.2021-0130 (DOI: 10.2176/nmccrj.cr.2021-0130)
26.	Nobuaki Yamamoto, Yuishin Izumi, Yuki Yamamoto, K Kuroda, Izumi Yamaguchi, Shu Sogabe, Takeshi Miyamoto, Kenji Shimada, Yasuhisa Kanematsu, Ryoma Morigaki and Yasushi Takagi : Factors associated with DWI-ASPECTS score in patients with acute ischemic stroke due to cerebral large vessel occlusion, Clinical Neurology and Neurosurgery, Vol.199, 106316, 2020. (Summary) The Alberta Stroke Program Early CT score (ASPECTS) of patients with acute ischemic stroke at the time of admission varies. It is crucial to select appropriate methods of treatment, such as recombinant tissue-plasminogen activator, and/or endovascular thrombectomy. According to the recent guidelines, endovascular thrombectomy for patients with large vessel occlusion (LVO) and lesion of ischemic tissue that was not yet infarcted is effective. This result demonstrates the importance of patient selection based on neuroradiological imaging. However, there are many patients who are judged as ineligibility for recanalization therapy because of presence of large ischemic core, indicating unfavorable ASPECTS, at the time of admission. We investigated the factors associated with favorable diffusion-weighted image (DWI)-ASPECTS score at the time of admission. We studies patients with LVO within 24 h from onset who were admitted into our hospital. We divided them into two groups, with favorable DWI-ASPECTS (≥6), and unfavorable DWI-ASPECTS (<6) at the time of admission. We investigated factors associated with favorable DWI-ASPECTS by evaluation of our patients' severity of clinical symptom, etiology, and radiological findings. This study showed that mild white matter lesion (Fazekas scale ≤1), absence of internal carotid artery (ICA) occlusion and cardioembolic stroke were independent factor of favorable DWI-ASPECTS at the time of admission. (odds ratio 12.92, p < 0.001, odds ratio 0.31, p = 0.001, odds ratio 0.16, p = 0.001, respectively) CONCLUSIONS: Absence of severe white matter lesion, cardioembolic stroke, and ICA occlusion might be associated with favorable DWI-ASPECTS at the time of admission. (Keyword) Aged / Aged, 80 and over / Brain Ischemia / Cerebrovascular Disorders / Diffusion Magnetic Resonance Imaging / Female / Humans / Ischemic Stroke / Male / Middle Aged / Patient Admission / Prospective Studies / Retrospective Studies / Severity of Illness Index (Link to Publication Site) ● Publication site (DOI): 10.1016/j.clineuro.2020.106316 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33161217 ● Search Scopus @ Elsevier (PMID): 33161217 ● Search Scopus @ Elsevier (DOI): 10.1016/j.clineuro.2020.106316 (DOI: 10.1016/j.clineuro.2020.106316, PubMed: 33161217)
27.	Shotaroh Yoshioka, Takeshi Miyamoto, Junichiro Satomi, Yoshiteru Tada, Kenji Yagi, Kenji Shimada, Koji Naruishi, Eiji Shikata, Izumi Yamaguchi, Tadashi Yamaguchi, Masaaki Korai, Yoshihiro Okayama, Masafumi Harada, Keiko Kitazato, Yasuhisa Kanematsu, Shinji Nagahiro and Yasushi Takagi : Disequilibrium of Plasma Protease/Anti-Protease Due to Severe Periodontal Disease Contributes to Human Subarachnoid Hemorrhage, Neurosurgery Open, Vol.1, No.3, 1-9, 2020. (Tokushima University Institutional Repository) ● Metadata: 115292 (Link to Publication Site) ● Publication site (DOI): 10.1093/neuopn/okaa007 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.1093/neuopn/okaa007 (Tokushima University Institutional Repository: 115292, DOI: 10.1093/neuopn/okaa007)
28.	Nobuaki Yamamoto, Yuki Yamamoto, Izumi Yamaguchi, Manabu Ishihara, Takeshi Miyamoto, Masaaki Korai, Kenji Shimada, Yasuhisa Kanematsu, Yuishin Izumi and Yasushi Takagi : Cone beam-computed tomography angiography by intravenous contrast injection is reliable to evaluate patients with large vessel occlusion, Journal of Clinical Neuroscience, Vol.70, 67-71, 2019. (Summary) Mechanical thrombectomy (MT) for acute ischemic stroke (AIS) patients due to emergent large vessel occlusion (ELVO) is standard treatment, the benefits, however, are highly time-sensitive. After patient eligibility for reperfusion therapy is determined by conventional radiological examinations, the time to be transferred from the department of radiological examination to angiography-suites is critical. We speculated that the time required for the diagnosis of AIS might be reduced if we could determine MT eligibility in patients with ELVO at angiography-suites. Modern angiography-suites with flat panel detectors can perform cone beam (CB)-CT. We performed CB-CTA using intravenous injection of contrast agent to evaluate occlusion sites, collateral score, and construction of vessels distal to occlusion sites and determined if CB-CTA could be useful to evaluate patients with ELVO. We included 15 patients with ELVO diagnosed by conventional MRI or CT/CTA, and investigated whether CB-CTA was reliable to diagnose occlusion sites. We also studied if collateral score on CB-CTA was associated with prognosis after successful reperfusion by MT by comparison between favorable (modified Rankin scale (mRS) 0-2), and unfavorable outcome group (mRS 3-6). There was strong agreement of occlusion sites between CB-CTA and conventional radiological examination (κ = 0.80). Collateral score determined by CB-CTA was significantly different between favorable outcome and unfavorable outcome group (median collateral score 2.3 v.s. 1.3, p = 0.040). Although prospective study of AIS patients at a radiography department is indispensable, CB-CTA performed in an angiography-suite might be useful to evaluate patients with ELVO. (Keyword) Aged / Aged, 80 and over / Brain Ischemia / Carotid Artery Thrombosis / Computed Tomography Angiography / Contrast Media / Female / Humans / Infarction, Middle Cerebral Artery / Injections, Intravenous / Male / Middle Aged / Prognosis / Reperfusion / Retrospective Studies / Thrombectomy / Treatment Outcome (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jocn.2019.08.078 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31445814 ● Summary page in Scopus @ Elsevier: 2-s2.0-85070874852 (DOI: 10.1016/j.jocn.2019.08.078, PubMed: 31445814, Elsevier: Scopus)
29.	Izumi Yamaguchi, Yasuhisa Kanematsu, Kenji Shimada, Masaaki Korai, Takeshi Miyamoto, Eiji Shikata, Tadashi Yamaguchi, Nobuaki Yamamoto, Yuki Yamamoto, Keiko Kitazato, Yoshihiro Okayama and Yasushi Takagi : Active Cancer and Elevated D-Dimer Are Risk Factors for In-Hospital Ischemic Stroke, Cerebrovascular Diseases Extra, Vol.9, No.3, 129-138, 2019. (Summary) Little attention has been paid to the pathogenesis of in-hospital stroke, despite poor outcomes and a longer time from stroke onset to treatment. We studied the pathophysiology and biomarkers for detecting patients who progress to in-hospital ischemic stroke (IHS). Seventy-nine patients with IHS were sequentially recruited in the period 2011-2017. Their characteristics, care, and outcomes were compared with 933 patients who had an out-of-hospital ischemic stroke (OHS) using a prospectively collected database of the Tokushima University Stroke Registry. Active cancer and coronary artery disease were more prevalent in patients with IHS than in those with OHS (53.2 and 27.8% vs. 2.0 and 10.9%, respectively; p < 0.001), the median onset-to-evaluation time was longer (300 vs. 240 min; p = 0.015), and the undetermined etiology was significantly higher (36.7 vs. 2.4%; p < 0.001). Although there was no significant difference in stroke severity at onset between the groups, patients with IHS had higher modified Rankin Scale (mRS) scores (3-6) at discharge (67.1 vs. 50.3%; p = 0.004) and rates of death during hospitalization (16.5 vs. 2.9%; p < 0.001). D-dimer (5.8 vs. 0.8 µg/mL; p < 0.001) and fibrinogen (532 vs. 430 mg/dL; p = 0.014) plasma levels at the time of onset were significantly higher in patients with IHS after propensity score matching. Multivariate logistic regression analysis revealed that active cancer (odds ratio [OR] 2.30; 95% confidence interval [CI] 1.26-4.20), prestroke mRS scores 3-5 (OR 6.78; 95% CI 3.96-11.61), female sex (OR 1.57; 95% CI 1.19-2.08), and age ≥75 years (OR 2.36; 95% CI 1.80-3.08) were associated with poor outcomes. Patients with IHS had poorer outcomes than those with OHS because of a higher prevalence of active cancer and functional dependence before stroke onset. Elevated plasma levels of D-dimer and fibrinogen, especially with active cancer, can help identify patients who are at a higher risk of progression to IHS. (Keyword) Aged / Aged, 80 and over / Biomarkers / Brain Ischemia / Databases, Factual / female / Fibrin Fibrinogen Degradation Products / Hospital Mortality / Hospitalization / Humans / Inpatients / Japan / male / Middle Aged / Neoplasms / Prevalence / Prognosis / Registries / Retrospective Studies / Risk Assessment / Risk Factors / Stroke / Time Factors / Up-Regulation (Tokushima University Institutional Repository) ● Metadata: 115057 (Link to Publication Site) ● Publication site (DOI): 10.1159/000504163 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31760390 ● Summary page in Scopus @ Elsevier: 2-s2.0-85075786196 (Tokushima University Institutional Repository: 115057, DOI: 10.1159/000504163, PubMed: 31760390, Elsevier: Scopus)
30.	Tadashi Yamaguchi, Takeshi Miyamoto, keiko Kitazato, Eiji Shikata, Izumi Yamaguchi, Masaaki Korai, Kenji Shimada, Kenji Yagi, Yoshiteru Tada, Yoshihito Matsuzaki, Yasuhisa Kanematsu and Yasushi Takagi : Time-dependent and site-dependent morphological changes in rupture-prone arteries: ovariectomized rat intracranial aneurysm model, Journal of Neurosurgery, 2019. (Summary) The pathogenesis of intracranial aneurysm rupture remains unclear. Because it is difficult to study the time course of human aneurysms and most unruptured aneurysms are stable, animal models are used to investigate the characteristics of intracranial aneurysms. The authors have newly established a rat intracranial aneurysm rupture model that features site-specific ruptured and unruptured aneurysms. In the present study the authors examined the time course of changes in the vascular morphology to clarify the mechanisms leading to rupture. Ten-week-old female Sprague-Dawley rats were subjected to hemodynamic changes, hypertension, and ovariectomy. Morphological changes in rupture-prone intracranial arteries were examined under a scanning electron microscope and the association with vascular degradation molecules was investigated. At 2-6 weeks after aneurysm induction, morphological changes and rupture were mainly observed at the posterior cerebral artery; at 7-12 weeks they were seen at the anterior Willis circle including the anterior communicating artery. No aneurysms at the anterior cerebral artery-olfactory artery bifurcation ruptured, suggesting that the inception of morphological changes is site dependent. On week 6, the messenger RNA level of matrix metalloproteinase-9, interleukin-1β, and the ratio of matrix metalloproteinase-9 to the tissue inhibitor of metalloproteinase-2 was significantly higher at the posterior cerebral artery, but not at the anterior communicating artery, of rats with aneurysms than in sham-operated rats. These findings suggest that aneurysm rupture is attributable to significant morphological changes and an increase in degradation molecules. Time-dependent and site-dependent morphological changes and the level of degradation molecules may be indicative of the vulnerability of aneurysms to rupture. (Tokushima University Institutional Repository) ● Metadata: 113804 (Link to Publication Site) ● Publication site (DOI): 10.3171/2019.6.JNS19777 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31518986 ● Search Scopus @ Elsevier (PMID): 31518986 ● Search Scopus @ Elsevier (DOI): 10.3171/2019.6.JNS19777 (Tokushima University Institutional Repository: 113804, DOI: 10.3171/2019.6.JNS19777, PubMed: 31518986)
31.	Eiji Shikata, Tetsuya Tamura, Kiyohito Shinno, Yoshihiro Okayama, Naoki Shinohara, Kenji Shimada, Yasuhisa Kanematsu, Keiko T Kitazato, Shinji Nagahiro and Yasushi Takagi : Importance of Managing the Water-Electrolyte Balance by Delivering the Optimal Minimum Amount of Water and Sodium After Subarachnoid Hemorrhage., World Neurosurgery, Vol.129, e352-e360, 2019. (Summary) After aneurysmal subarachnoid hemorrhage (aSAH), crystalloid fluids with a relatively high sodium concentration have been used to maintain the cerebral blood flow. However, the prophylactic delivery of water and sodium by intravenous (IV) infusion will not necessarily improve the prognosis of patients after aSAH, and the excessive supply of water and sodium can negatively affect the outcome. We hypothesized that the delivery of an optimal amount of water and sodium separately might improve the outcome after aSAH. We recruited 55 consecutive patients who had undergone clipping or endovascular coil embolization after aSAH. Group 1 (n = 33) received conventional therapy (i.e., prophylactic IV sodium and water [protocol 1]). Group 2 (n = 22) received the optimal amount of water and sodium separately (protocol 2). The median total of water and sodium chloride supplied in group 1 was significantly greater than that supplied in group 2 (P < 0.01). The modified Rankin scale score at discharge was 0-2 in 15 patients (95%) in group 2 and 23 patients (55%) in group 1 (P < 0.001). On multivariate logistic regression analysis, the odds ratio for a discharge modified Rankin scale score of 0-2 or 3-6 was significantly associated with the treatment protocol (P < 0.05) and the net fluid balance on days 4-8 (P < 0.05). The separate delivery of optimal amounts of water and sodium could be a promising therapeutic strategy to improve the prognosis after aSAH. (Keyword) Administration, Intravenous / Aged / Embolization, Therapeutic / Female / Fluid Therapy / Humans / Male / Middle Aged / Postoperative Care / Retrospective Studies / Subarachnoid Hemorrhage / Treatment Outcome / Water-Electrolyte Balance (Link to Publication Site) ● Publication site (DOI): 10.1016/j.wneu.2019.05.152 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31132492 ● Search Scopus @ Elsevier (PMID): 31132492 ● Search Scopus @ Elsevier (DOI): 10.1016/j.wneu.2019.05.152 (DOI: 10.1016/j.wneu.2019.05.152, PubMed: 31132492)
32.	Toshiyuki Okazaki, Yasuhisa Kanematsu, Kenji Shimada, Masaaki Korai, Junichiro Satomi, Masaaki Uno, Shinji Nagahiro and Yasushi Takagi : A Single-center Retrospective Study with 5- and 10-year Follow-up of Carotid Endarterectomy with Patch Graft., Neurologia Medico-Chirurgica, Vol.59, No.6, 231-237, 2019. (Summary) Carotid endarterectomy (CEA) is widely used for cervical artery stenosis. In Japan, primary closure after endarterectomy has been a standard technique. Recently, the patch closure has been shown to be superior to the primary suture for the prevention of restenosis and ipsilateral stroke. This study evaluated the 5- and 10-year outcomes following CEA with patch graft closure in our institution. Between January 2000 and March 2013, 134 patients, who underwent CEA with patch graft closure were investigated in the current retrospective study. Among these patients, 102 CEAs in 97 patients were followed up for 5 years and 66 CEAs in 61 patients were for 10 years after the procedure. Restenosis was defined as >50% recurrent luminal narrowing at the endarterectomy site. In 5 years, symptomatic restenosis exhibited minor stroke in one patient at 58 months after CEA (restenosis rate 1.0%). The ipsilateral minor stroke occurred in three patients including the above case (2.9%). In 10 years, asymptomatic restenosis occurred in three patients in addition to the above symptomatic case (restenosis rate 6.1%), and the ipsilateral minor stroke occurred in four patients (6.1%). Carotid endarterectomy with patch graft exerted a high protective effect from restenosis up to 5 and 10 years in our institution. The number of carotid artery stenting is increasing all over the world but we speculated that the established surgical procedure of patched CEA prevented restenosis and ipsilateral stroke. (Keyword) Aged / Blood Vessel Prosthesis Implantation / Carotid Stenosis / Endarterectomy, Carotid / Female / Follow-Up Studies / Graft Occlusion, Vascular / Humans / Male / Middle Aged / Postoperative Complications / Retrospective Studies / Stents / Stroke / Time Factors (Tokushima University Institutional Repository) ● Metadata: 119185 (Link to Publication Site) ● Publication site (DOI): 10.2176/nmc.oa.2018-0309 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31061257 ● Search Scopus @ Elsevier (PMID): 31061257 ● Search Scopus @ Elsevier (DOI): 10.2176/nmc.oa.2018-0309 (Tokushima University Institutional Repository: 119185, DOI: 10.2176/nmc.oa.2018-0309, PubMed: 31061257)
33.	Yamamoto Yuki, Nobuaki Yamamoto, Yasuhisa Kanematsu, Masaaki Korai, Kenji Shimada, Yuishin Izumi and Yasushi Takagi : The Claw Sign: An angiographic Predictor of Recanalization After Mechanical Thrombectomy for Cerebral Large Vessel Occlusion., Journal of Stroke & Cerebrovascular Diseases, Vol.28, No.6, 1555-1560, 2019. (Summary) Mechanical thrombectomy undoubtedly improves functional outcomes for patients with acute ischemic stroke. Although we have observed occlusion sites that protrude proximally into the vessel on angiography, termed the "claw sign," we have been unable to state its clinical significance. In this study, we aimed to determine whether the presence of a claw sign was related to recanalization success after mechanical thrombectomy. We retrospectively included 73 consecutive patients treated for acute cerebral large vessel occlusion by mechanical thrombectomy between January 2014 and December 2017. The angiographic claw sign was defined as a thrombus that protruded proximally by more than half the diameter of the parent artery. Claw sign positivity, clinical and etiological features, and outcomes were compared between groups with and without recanalization. The claw sign was observed in 29 of 73 (40%) patients and was positive significantly more frequently in those with recanalization (50.0%) than in those without recanalization (5.9%) (P < .01). By multivariate analysis, the claw sign was the only pretreatment parameter to predict successful recanalization (odds ratio, 12.50; 95% confidence interval, 1.50-103.00; P = .019). The presence of the claw sign might predict successful recanalization in patients undergoing mechanical thrombectomy for large vessel occlusion. (Keyword) Aged / Aged, 80 and over / Angiography, Digital Subtraction / Cerebral Angiography / Cerebral Arteries / Cerebrovascular Circulation / Constriction, Pathologic / Female / Humans / Intracranial Thrombosis / Male / Middle Aged / Predictive Value of Tests / Retrospective Studies / Thrombectomy / Thrombolytic Therapy / Treatment Outcome / Vascular Patency (Tokushima University Institutional Repository) ● Metadata: 114639 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jstrokecerebrovasdis.2019.03.007 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 30930237 ● Search Scopus @ Elsevier (PMID): 30930237 ● Search Scopus @ Elsevier (DOI): 10.1016/j.jstrokecerebrovasdis.2019.03.007 (Tokushima University Institutional Repository: 114639, DOI: 10.1016/j.jstrokecerebrovasdis.2019.03.007, PubMed: 30930237)
34.	Akemi Hioka, Yoshiteru Tada, Keiko Kitazato, Yasuhisa Kanematsu, Yoshifumi Mizobuchi, Hideo Mure, Kenji Shimada, Toshiyuki Okazaki, Masaaki Korai, Noki Akazawa, Yuki Matsumoto, Yuki Matsumoto, Yasushi Takagi and Shinji Nagahiro : Activation of mirror neuron system during gait observation in sub-acute stroke patients and healthy persons., Journal of Clinical Neuroscience, Vol.60, 79-83, 2019. (Summary) The observation of walking improves gait ability in chronic stroke survivors. It has also been suggested that activation of the mirror neuron system contributes to this effect. However, activation of the mirror neuron system during gait observation has not yet been assessed in sub-acute stroke patients. The objective of this study was to clarify the activation of mirror neuron system during gait observation in sub-acute stroke patients and healthy persons. In this study, we sequentially enrolled five sub-acute stroke patients who had undergone gait training and nine healthy persons. We used fMRI to detect neuronal activation during gait observation. During the observation period in the stroke group, neural activity in the left inferior parietal lobule, right and left inferior frontal gyrus was significantly higher than during the rest period. In the healthy group, neural activity in the left inferior parietal lobule, left inferior frontal gyrus, left middle frontal gyrus, left superior temporal lobule and right and left middle temporal gyrus was significantly higher than during the rest period. The results indicate that the mirror neuron system was activated during gait observation in sub-acute stroke patients who had undergone gait training and also in healthy persons. Our findings suggest that gait observation treatment may provide a promising therapeutic strategy in sub-acute stroke patients who have experienced gait training. (Keyword) Adult / Brain / Exercise Therapy / Female / Gait / Humans / Magnetic Resonance Imaging / Male / Middle Aged / Mirror Neurons / Stroke / Stroke Rehabilitation (Tokushima University Institutional Repository) ● Metadata: 113267 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jocn.2018.09.035 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 30318398 ● Search Scopus @ Elsevier (PMID): 30318398 ● Search Scopus @ Elsevier (DOI): 10.1016/j.jocn.2018.09.035 (Tokushima University Institutional Repository: 113267, DOI: 10.1016/j.jocn.2018.09.035, PubMed: 30318398)
35.	Nobuaki Yamamoto, Yuki Yamamoto, Masaaki Korai, Kenji Shimada, Yasuhisa Kanematsu, Yuishin Izumi, Junichiro Satomi, Yasushi Takagi and Ryuji Kaji : Simultaneous approach to tandem occlusion in acute ischemic stroke patients: Percutaneous Transluminal Angioplasty (PTA) using push wire of stent retriever, Journal of Neuroendovascular Therapy, Vol.13, No.6, 257-261, 2019. (Link to Publication Site) ● Publication site (DOI): 10.5797/jnet.cr.2018-0108 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390001288147947776 ● Search Scopus @ Elsevier (DOI): 10.5797/jnet.cr.2018-0108 (DOI: 10.5797/jnet.cr.2018-0108, CiNii: 1390001288147947776)
36.	Shinji Nagahiro, Yoshiteru Tada, Junichiro Satomi, Tomoya Kinouchi, Kazuyuki Kuwayama, Kenji Yagi, Kohhei Nakajima, Nobuhisa Matsushita, Takeshi Miyamoto, Tadashi Yamaguchi, Kenji Shimada, Masaaki Korai, Hideo Mure, Y Okayama, Takashi Abe, Masafumi Harada, Keiko T. Kitazato and Yasuhisa Kanematsu : Treatment of Unruptured Cerebral Aneurysms with the Mineralocorticoid Receptor Blocker Eplerenone-Pilot Study., Journal of Stroke & Cerebrovascular Diseases, Vol.27, No.8, 2134-2140, 2018. (Summary) Currently there are no pharmacological therapies for patients with unruptured cerebral aneurysms. Elsewhere we showed that the mineralocorticoid receptor antagonist eplerenone prevented the formation of cerebral aneurysms in our ovariectomized hypertensive aneurysm rat model. The current pilot study evaluated whether it can be used to prevent the growth and rupture of cerebral aneurysms in hypertensive patients. Between August 2011 and May 2014, we enrolled 82 patients with 90 aneurysms in an open-label uncontrolled clinical trial. All provided prior informed consent for inclusion in this study, and all were treated with eplerenone (25-100 mg/d). The primary end points of our study were the rupture and enlargement of the cerebral aneurysms. Of the 82 patients, 80 (88 unruptured aneurysms) were followed for a mean of 21.3 months (153.4 aneurysm-years); 12 patients (15.0%) permanently discontinued taking the drug. One month after the start of eplerenone administration and throughout the follow-up period, eplerenone kept the blood pressure within the normal range. Most notably, no aneurysms smaller than 9 mm ruptured or enlarged. However, of 2 large thrombosed aneurysms, 1 enlarged and the other ruptured. The overall annual rupture rate was .65%; it was 13.16% for aneurysms larger than 10 mm; the overall annual rate for reaching the primary end points was 1.30%. Our observations suggest that eplerenone may help to prevent the growth and rupture of unruptured cerebral aneurysms smaller than 9 mm. To assess its potential long-term clinical benefits, large clinical trials are needed. (Keyword) Aged / Aneurysm, Ruptured / brain / Disease Progression / female / Follow-Up Studies / Humans / Intracranial Aneurysm / male / Mineralocorticoid Receptor Antagonists / Neuroprotective Agents / Pilot Projects / Spironolactone / Treatment Outcome (Tokushima University Institutional Repository) ● Metadata: 115570 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jstrokecerebrovasdis.2018.03.008 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 29622372 ● Summary page in Scopus @ Elsevier: 2-s2.0-85049537109 (Tokushima University Institutional Repository: 115570, DOI: 10.1016/j.jstrokecerebrovasdis.2018.03.008, PubMed: 29622372, Elsevier: Scopus)
37.	Masaaki Korai, 北里慶子, Yoshiteru Tada, Takeshi Miyamoto, Kenji Shimada, Nobuhisa Matsushita, Yasuhisa Kanematsu, Junichiro Satomi, 橋本友紀 and Shinji Nagahiro : Hyperhomocysteinemia induced by excessive methionine intake promotes rupture of cerebral aneurysms in ovariectomized rats, Journal of Neuroinflammation, Vol.13, No.1, 165, 2016. (Summary) Hyperhomocysteinemia (HHcy) is associated with inflammation and a rise in the expression of matrix metalloproteinase-9 (MMP-9) in the vascular wall. However, the role of HHcy in the growth and rupture of cerebral aneurysms remains unclear. Thirteen-week-old female Sprague-Dawley rats were subject to bilateral ovariectomy and ligation of the right common carotid artery and fed an 8 % high-salt diet to induce cerebral aneurysms. Two weeks later, they underwent ligation of the bilateral posterior renal arteries. They were divided into two groups and methionine (MET) was or was not added to their drinking water. In another set of experiments, the role of folic acid (FA) against cerebral aneurysms was assessed. During a 12-week observation period, subarachnoid hemorrhage due to aneurysm rupture was observed at the anterior communicating artery (AcomA) or the posterior half of the circle of Willis. HHcy induced by excessive MET intake significantly increased the incidence of ruptured aneurysms at 6-8 weeks. At the AcomA of rats treated with MET, we observed the promotion of aneurysmal growth and infiltration by M1 macrophages. Furthermore, the mRNA level of MMP-9, the ratio of MMP-9 to the tissue inhibitor of metalloproteinase-2, and the level of interleukin-6 were higher in these rats. Treatment with FA abolished the effect of MET, suggesting that the inflammatory response and vascular degradation at the AcomA is attributable to HHcy due to excessive MET intake. We first demonstrate that in hypertensive ovariectomized rats, HHcy induced by excessive MET intake may be associated with the propensity of the aneurysm wall to rupture. (Tokushima University Institutional Repository) ● Metadata: 110031 (Link to Publication Site) ● Publication site (DOI): 10.1186/s12974-016-0634-3 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27349749 ● Search Scopus @ Elsevier (PMID): 27349749 ● Search Scopus @ Elsevier (DOI): 10.1186/s12974-016-0634-3 (Tokushima University Institutional Repository: 110031, DOI: 10.1186/s12974-016-0634-3, PubMed: 27349749)
38.	Takeshi Miyamoto, DK Kung, KT Kitazato, Kenji Yagi, Kenji Shimada, Yoshiteru Tada, Masaaki Korai, Yoshitaka Kurashiki, Tomoya Kinouchi, Yasuhisa Kanematsu, Junichiro Satomi, T Hashimoto and Shinji Nagahiro : Site-specific elevation of interleukin-1β and matrix metalloproteinase-9 in the Willis circle by hemodynamic changes is associated with rupture in a novel rat cerebral aneurysm model, Journal of Cerebral Blood Flow and Metabolism, Vol.37, No.8, 2795-2805, 2016. (Summary) The pathogenesis of subarachnoid hemorrhage remains unclear. No models of cerebral aneurysms elicited solely by surgical procedures and diet have been established. Elsewhere we reported that only few rats in our original rat aneurysm model manifested rupture at the anterior and posterior Willis circle and that many harbored unruptured aneurysms at the anterior cerebral artery-olfactory artery bifurcation. This suggests that rupture was site-specific. To test our hypothesis that a site-specific response to hemodynamic changes is associated with aneurysmal rupture, we modified our original aneurysm model by altering the hemodynamics. During 90-day observation, the incidence of ruptured aneurysms at the anterior and posterior Willis circle was significantly increased and the high incidence of unruptured aneurysms at the anterior cerebral artery-olfactory artery persisted. This phenomenon was associated with an increase in the blood flow volume. Notably, the level of matrix metalloproteinase-9 associated with interleukin-1β was augmented by the increase in the blood flow volume, suggesting that these molecules exacerbated the vulnerability of the aneurysmal wall. The current study first demonstrates that a site-specific increase in interleukin-1β and matrix metalloproteinase-9 elicited by hemodynamic changes is associated with rupture. Our novel rat model of rupture may help to develop pharmaceutical approaches to prevent rupture. (Tokushima University Institutional Repository) ● Metadata: 110032 (Link to Publication Site) ● Publication site (DOI): 10.1177/0271678X16675369 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27798272 ● Search Scopus @ Elsevier (PMID): 27798272 ● Search Scopus @ Elsevier (DOI): 10.1177/0271678X16675369 (Tokushima University Institutional Repository: 110032, DOI: 10.1177/0271678X16675369, PubMed: 27798272)
39.	Kenji Shimada, Hjime Furukawa, Kousuke Wada, Masaaki Kohrai, Yuan Wei, Yoshiteru Tada, Atsushi Kuwahara, Fumiaki Shikata, Keiko T. Kitazato, Shinji Nagahiro, Michael T. Lawton and Tomoki Hashimoto : Protective role of peroxisome proliferator-activated receptor- in the development of intracranial aneurysm rupture, Stroke, Vol.46, No.6, 1664-1672, 2015. (Summary) Inflammation is emerging as a key component of the pathophysiology of intracranial aneurysms. Peroxisome proliferator-activated receptor-γ (PPARγ) is a nuclear hormone receptor of which activation modulates various aspects of inflammation. Using a mouse model of intracranial aneurysm, we examined the potential roles of PPARγ in the development of rupture of intracranial aneurysm. A PPARγ agonist, pioglitazone, significantly reduced the incidence of ruptured aneurysms and the rupture rate without affecting the total incidence aneurysm (unruptured aneurysms and ruptured aneurysms). PPARγ antagonist (GW9662) abolished the protective effect of pioglitazone. The protective effect of pioglitazone was absent in mice lacking macrophage PPARγ. Pioglitazone treatment reduced the mRNA levels of inflammatory cytokines (monocyte chemoattractant factor-1, interleukin-1, and interleukin-6) that are primarily produced by macrophages in the cerebral arteries. Pioglitazone treatment reduced the infiltration of M1 macrophage into the cerebral arteries and the macrophage M1/M2 ratio. Depletion of macrophages significantly reduced the rupture rate. Our data showed that the activation of macrophage PPARγ protects against the development of aneurysmal rupture. PPARγ in inflammatory cells may be a potential therapeutic target for the prevention of aneurysmal rupture. (Keyword) Aneurysm, Ruptured / Anilides / Animals / Cerebral Arteries / cytokinesis / Hypoglycemic Agents / Intracranial Aneurysm / Macrophages / Mice / knockout mice / PPAR gamma / Thiazolidinediones (Link to Publication Site) ● Publication site (DOI): 10.1161/STROKEAHA.114.007722 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25931465 ● Summary page in Scopus @ Elsevier: 2-s2.0-84942924464 (DOI: 10.1161/STROKEAHA.114.007722, PubMed: 25931465, Elsevier: Scopus)
40.	Yoshiteru Tada, Kenji Yagi, Masaaki Uno, Nobuhisa Matsushita, Yasuhisa Kanematsu, Kazuyuki Kuwayama, Kenji Shimada, Kyoko Nishi, Motohiro Hirasawa, Junichiro Satomi, KT Kitazato, Teruyoshi Kageji, E Matsumura and Shinji Nagahiro : Improvement of plasma biomarkers after switching stroke patients from other angiotensin II type I receptor blockers to olmesartan, Journal of Stroke & Cerebrovascular Diseases, Vol.24, 1487-1492, 2015. (Summary) Managing hypertension is crucial for preventing stroke recurrence. Some stroke patients experience resistant hypertension. In our experimental stroke model, olmesartan increased the expression of angiotensin (Ang) II converting enzyme-2. We hypothesized that switching to olmesartan affects biomarkers and the blood pressure (BP) in stroke patients whose BP is insufficiently controlled by standard doses of Ang II type I receptor blockers (ARBs) other than olmesartan. We recruited 25 patients to study our hypothesis. All had a history of stroke or silent cerebral infarction. We switched them to olmesartan (10-40 mg per day) for 12 weeks and determined their plasma level of Ang-(1-7), peroxiredoxin, oxidized low-density lipoprotein (oxLDL)/β-2-glycoprotein I (β2GPI) complex, adiponectin, high mobility group box 1 (HMGB1), and tumor necrosis factor-α (TNFα) and recorded their BP before and after olmesartan treatment. After switching the patients to olmesartan, their plasma level of Ang-(1-7) as a vasoprotective indicator and adiponectin regulating metabolic syndrome was increased, and peroxiredoxin and the oxLDL/β2GPI complex indicating its antioxidative stress and its proatherogenicity were lower than their baseline. This suggests that olmesartan may be more effective than other ARBs to improve these conditions. Neither HMGB1 nor TNFα reflecting an inflammatory response was affected, suggesting that the anti-inflammatory effects of olmesartan are similar to those of other ARBs. The recommended BP (<140/90) was obtained in 10 of the 25 patients after switching to olmesartan. No adverse events occurred. Switching from other ARBs to olmesartan may be a promising therapeutic option in patients with resistant hypertension. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jstrokecerebrovasdis.2015.03.015 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25891757 ● Summary page in Scopus @ Elsevier: 2-s2.0-84930820228 (DOI: 10.1016/j.jstrokecerebrovasdis.2015.03.015, PubMed: 25891757, Elsevier: Scopus)
41.	Kenji Shimada, Hajime Furukawa, Kosuke Wada, Yuan Wei, Yoshiteru Tada, Atsushi Kuwabara, Fumiaki Shikata, Yasuhisa Kanematsu, Michael T. Lawton, Keiko T. Kitazato, Shinji Nagahiro and Tomoki Hashimoto : Angiotensin-(1-7) protects against the development of aneurysmal subarachnoid hemorrhage in mice, Journal of Cerebral Blood Flow and Metabolism, Vol.35, No.7, 1163-1168, 2015. (Summary) Angiotensin-(1-7) (Ang-(1-7)) can regulate vascular inflammation and remodeling, which are processes that have important roles in the pathophysiology of intracranial aneurysms. In this study, we assessed the effects of Ang-(1-7) in the development of intracranial aneurysm rupture using a mouse model of intracranial aneurysms in which aneurysmal rupture (i.e., aneurysmal subarachnoid hemorrhage) occurs spontaneously and causes neurologic symptoms. Treatment with Ang-(1-7) (0.5 mg/kg/day), Mas receptor antagonist (A779 0.5 mg/kg/day or 2.5 mg/kg/day), or angiotensin II type 2 receptor (AT2R) antagonist (PD 123319, 10 mg/kg/day) was started 6 days after aneurysm induction and continued for 2 weeks. Angiotensin-(1-7) significantly reduced the rupture rate of intracranial aneurysms without affecting the overall incidence of aneurysms. The protective effect of Ang-(1-7) was blocked by the AT2R antagonist, but not by the Mas receptor antagonist. In AT2R knockout mice, the protective effect of Ang-(1-7) was absent. While AT2R mRNA was abundantly expressed in the cerebral arteries and aneurysms, Mas receptor mRNA expression was very scarce in these tissues. Angiotensin-(1-7) reduced the expression of tumor necrosis factor-α and interleukin-1β in cerebral arteries. These findings indicate that Ang-(1-7) can protect against the development of aneurysmal rupture in an AT2R-dependent manner. (Keyword) Aneurysm, Ruptured / Angiotensin I / Angiotensin II / Angiotensin II Type 2 Receptor Blockers / Animals / brain / Cerebral Arteries / cytokinesis / Imidazoles / Male / Mice / Mice, Inbred C57BL / knockout mice / Peptide Fragments / Pyridines / RNA, Messenger / Receptor, Angiotensin, Type 2 / Subarachnoid Hemorrhage (Link to Publication Site) ● Publication site (DOI): 10.1038/jcbfm.2015.30 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25757758 ● Summary page in Scopus @ Elsevier: 2-s2.0-84934443499 (DOI: 10.1038/jcbfm.2015.30, PubMed: 25757758, Elsevier: Scopus)
42.	Yoshiteru Tada, Hiroshi Makino, Hajime Furukawa, Kenji Shimada, Kosuke Wada, EI Liang, Shoko Murakami, Mari Kudo, DK Kung, KT Kitazato, Shinji Nagahiro, MT Lawton and Tomoki Hashimoto : Roles of estrogen in the formation of intracranial aneurysms in ovariectomized female mice, Neurosurgery, Vol.75, No.6, 690-695, 2014. (Summary) Epidemiological studies have indicated that postmenopausal women have a higher incidence of intracranial aneurysms than men in the same age group. To investigate whether estrogen or estrogen receptors (ERs) mediate protective effects against the formation of intracranial aneurysms. Intracranial aneurysms were induced in mice by combining a single injection of elastase into the cerebrospinal fluid with deoxycorticosterone acetate salt hypertension. The mice were treated with estrogen (17β-estradiol), an ERα agonist (propyl pyrazole triol), and an ERβ agonist (diarylpropionitrile) with and without a nitric oxide synthase inhibitor. The ovariectomized female mice had a significantly higher incidence of aneurysms than the male mice, which was consistent with findings in previous epidemiological studies. In ovariectomized female mice, an ERβ agonist, but not an ERα agonist or 17β-estradiol, significantly reduced the incidence of aneurysms. The protective effect of the ERβ agonist was absent in the ovariectomized ERβ knockout mice. The protective effect of the ERβ agonist was negated by treatment with a nitric oxide synthase inhibitor. The effects of sex, menopause, and estrogen treatment observed in this animal study were consistent with previous epidemiological findings. Stimulation of estrogen receptor-β was protective against the formation of intracranial aneurysms in ovariectomized female mice. (Keyword) Animals / Disease Models, Animal / Estradiol / Estrogen Receptor alpha / Estrogen Receptor beta / Estrogens / Female / Intracranial Aneurysm / Male / Mice / Mice, Knockout / Nitriles / Ovariectomy / Propionates / Pyrazoles / Sex Characteristics (Link to Publication Site) ● Publication site (DOI): 10.1227/NEU.0000000000000528 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25181430 ● Summary page in Scopus @ Elsevier: 2-s2.0-84925871499 (DOI: 10.1227/NEU.0000000000000528, PubMed: 25181430, Elsevier: Scopus)
43.	Yoshiteru Tada, K Wada, Kenji Shimada, H Makino, EI Liang, S Murakami, M Kudo, F Shikata, RAP Silva, KT Kitazato, DM Hasan, Yasuhisa Kanematsu, Shinji Nagahiro and T Hashimoto : Estrogen protects against intracranial aneurysm rupture in ovariectomized mice, Hypertension, Vol.63, 1339-1344, 2014. (Summary) Clinical observations suggest that postmenopausal women have a higher incidence of aneurysmal rupture than premenopausal women. We hypothesize that a relative deficiency in estrogen may increase the risks of aneurysmal growth and subarachnoid hemorrhage in postmenopausal women. We assessed the effects of estrogen and selective estrogen receptor subtype agonists on the development of aneurysmal rupture in ovariectomized female mice. We used an intracranial aneurysm mouse model that recapitulates the key features of human intracranial aneurysms, including spontaneous rupture. Ten- to 12-week-old ovariectomized female mice received treatment with estrogen, nonselective estrogen receptor antagonist, estrogen receptor-α agonist, or estrogen receptor-β agonist starting 6 days after aneurysm induction so that the treatments affected the development of aneurysmal rupture without affecting aneurysmal formation. Estrogen significantly reduced the incidence of ruptured aneurysms and rupture rates in ovariectomized mice. Nonselective estrogen receptor antagonist abolished the protective effect of estrogen. Although estrogen receptor-α agonist did not affect the incidence of ruptured aneurysms or rupture rates, estrogen receptor-β agonist prevented aneurysmal rupture without affecting the formation of aneurysms. The protective role of estrogen receptor-β agonist was abolished by the inhibition of nitric oxide synthase. We showed that estrogen prevented aneurysmal rupture in ovariectomized female mice. The protective effect of estrogen seemed to occur through the activation of estrogen receptor-β, a predominant subtype of estrogen receptor in human intracranial aneurysms and cerebral arteries. (Keyword) Aged / Aneurysm, Ruptured / Animals / Disease Models, Animal / Enzyme Inhibitors / Estradiol / Estrogen Antagonists / Estrogen Receptor alpha / Estrogen Receptor beta / Estrogens / Female / Humans / Intracranial Aneurysm / Mice / Mice, Inbred C57BL / Middle Aged / NG-Nitroarginine Methyl Ester / Nitric Oxide / Nitric Oxide Synthase / Nitriles / Ovariectomy / Pyrazoles / Subarachnoid Hemorrhage (Link to Publication Site) ● Publication site (DOI): 10.1161/HYPERTENSIONAHA.114.03300 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 24732889 ● Search Scopus @ Elsevier (PMID): 24732889 ● Search Scopus @ Elsevier (DOI): 10.1161/HYPERTENSIONAHA.114.03300 (DOI: 10.1161/HYPERTENSIONAHA.114.03300, PubMed: 24732889)
44.	Yoshiteru Tada, Wada Kosuke, Kenji Shimada, Makino Hiroshi, EI Liang, Murakami Shoko, Kudo Mari, KT Kitazato, Shinji Nagahiro and Hashimoto Tomoki : Roles of hypertension in the rupture of intracranial aneurysms, Stroke, Vol.45, No.2, 579-586, 2014. (Summary) Systemic hypertension has long been considered a risk factor of aneurysmal rupture. However, a causal link between systemic hypertension and the development of aneurysmal rupture has not been established. In this study, using a mouse model of intracranial aneurysm rupture, we examined the roles of systemic hypertension in the development of aneurysmal rupture. Aneurysms were induced by a combination of deoxycorticosterone acetate (DOCA)-salt and a single injection of elastase into the cerebrospinal fluid in mice. Antihypertensive treatment was started 6 days after aneurysm induction. Aneurysmal rupture was detected by neurological symptoms and confirmed by the presence of intracranial aneurysm with subarachnoid hemorrhage. Hydralazine (direct vasodilator) or discontinuation of DOCA-salt treatment was used to assess the roles of systemic hypertension. Captopril (angiotensin-converting enzyme inhibitor) or losartan (angiotensin II type 1 receptor antagonist) was used to assess the roles of the local renin-angiotensin system in the vascular wall. Normalization of blood pressure by hydralazine significantly reduced the incidence of ruptured aneurysms and the rupture rate. There was a dose-dependent relationship between reduction of blood pressure and prevention of aneurysmal rupture. Captopril and losartan were able to reduce rupture rate without affecting systemic hypertension induced by DOCA-salt treatment. Normalization of blood pressure after aneurysm formation prevented aneurysmal rupture in mice. In addition, we found that the inhibition of the local renin-angiotensin system independent from the reduction of blood pressure can prevent aneurysmal rupture. (Keyword) Aneurysm, Ruptured / Animals / Antihypertensive Agents / Blood Pressure / Captopril / Desoxycorticosterone Acetate / Dose-Response Relationship, Drug / Hydralazine / Hypertension / Intracranial Aneurysm / Losartan / Male / Mice / Mice, Inbred C57BL / Pancreatic Elastase / Renin-Angiotensin System / Risk Factors / Subarachnoid Hemorrhage / Survival Analysis / Treatment Outcome (Link to Publication Site) ● Publication site (DOI): 10.1161/STROKEAHA.113.003072 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 24370755 ● Summary page in Scopus @ Elsevier: 2-s2.0-84893815565 (DOI: 10.1161/STROKEAHA.113.003072, PubMed: 24370755, Elsevier: Scopus)
45.	Tomoya Kinouchi, Keiko T. Kitazato, Kenji Shimada, Kenji Yagi, Yoshiteru Tada, Nobuhisa Matsushita, Manabu Sumiyoshi, Junichiro Satomi, Teruyoshi Kageji and Shinji Nagahiro : Activation of signal transducer and activator of transcription-3 by a peroxisome proliferator-activated receptor gamma agonist contributes to neuroprotection in the peri-infarct region after ischemia in oophorectomized rats, Stroke, Vol.43, No.2, 478-483, 2012. (Summary) The role of the phosphorylated signal transducer and activator of transcription-3 (p-STAT3) after cerebral ischemia by the peroxisome proliferator-activated receptor (PPAR) agonist pioglitazone (PGZ) remains controversial. Whether the increase in p-STAT3 by estrogen is mediated by the estrogen receptor is also obscure. We examined the role of p-STAT3, PPAR, and estrogen receptor against ischemic brain damage after PGZ treatment. Female Wistar rats subjected or not subjected to bilateral oophorectomy were injected with 1.0 or 2.5 mg/kg PGZ 2 days, 1 day, and 1 hour before 90-minute middle cerebral artery occlusion-reperfusion and compared with vehicle-control rats. The cortical infarct size was larger in ovariectomized than in nonovarietomized rats; it was reduced by PGZ treatment. Inversely with the reduction of the infarct size, PPAR, and p-STAT3 but not estrogen receptor in the peri-infarct area were increased in PGZ-treated compared with vehicle-control rats. The increase in PPAR and p-STAT3 was associated with the transactivation of antiapoptotic and survival genes and the reduction of caspase-3 in this area. Inhibitors of PPAR or STAT3 abolished the PGZ-induced neuroprotection and the increase in p-STAT3. More importantly, p-STAT3 increased by PGZ was bound to PPAR and the complex translocated to the nucleus to dock to the response element through p-STAT3. Our findings suggest that the activation in the peri-infarct region of p-STAT3 and PPAR by PGZ is essential for neuroprotection after ischemia and that PGZ may be of benefit even in postmenopausal stroke patients. (Keyword) Animals / Apoptosis / Basal Ganglia / Brain / Brain Ischemia / Caspase 3 / Cell Nucleus / Cerebral Infarction / DNA / Estrogen Receptor alpha / Female / Neuroprotective Agents / Ovariectomy / PPAR gamma / Protein Transport / Rats / Rats, Wistar / Response Elements / STAT3 Transcription Factor / Thiazolidinediones / Transcriptional Activation (Link to Publication Site) ● Publication site (DOI): 10.1161/STROKEAHA.111.618926 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22076002 ● Search Scopus @ Elsevier (PMID): 22076002 ● Search Scopus @ Elsevier (DOI): 10.1161/STROKEAHA.111.618926 (DOI: 10.1161/STROKEAHA.111.618926, PubMed: 22076002)
46.	Nobuhisa Matsushita, Keiko T. Kitazato, Yoshiteru Tada, Manabu Sumiyoshi, Kenji Shimada, Kenji Yagi, Yasuhisa Kanematsu, Junichiro Satomi and Shinji Nagahiro : Increase in body Na⁺-to-water ratio is associated with cerebral aneurysm formation in oophorectomized rats, Hypertension, Vol.60, No.5, 1309-1315, 2012. (Summary) The incidence of cerebral aneurysms is higher in women than in men, especially postmenopause. Although hypertension is thought to be associated with a high incidence of stroke, not all patients with unruptured cerebral aneurysms are hypertensive. The possibility of water-free Na(+) storage associated with hypertension has been raised. However, whether the increase in the body Na(+)/water ratio that characterizes water-free Na(+) accumulation is associated with the formation of cerebral aneurysms remains obscure. To examine this relationship, Sprague-Dawley female rats subjected to carotid artery ligation were divided into 3 groups: a high-salt diet group (HSD) without and another with bilateral oophorectomy (HSD/OVX) and a third group that underwent additional renal artery ligation (HSD/OVX/RL). Compared with rats receiving a normal diet (shams), water retention was increased in HSD rats but not in HSD/OVX rats. Interestingly, compared with HSD rats, the incidence of cerebral aneurysms and the body Na(+)/water ratio were significantly higher in HSD/OVX and HSD/OVX/RL rats, independent of hypertension. In their aneurysmal wall, ATP12, a subtype of Na(+)/K(+)-ATPase, was downregulated, whereas inflammatory-related molecules were upregulated. Treatment with low-dose olmesartan that did not affect the blood pressure in hypertensive HSD/OVX/RL rats reduced the rate of cerebral aneurysm formation, body Na(+) retention, and the Na(+)/water ratio and upregulated ATP12. These results suggest that the increase in the Na(+)/water ratio and a reduction in ATP12 may be associated with cerebral aneurysm formation. We provide the new insight that the management of water-free Na(+) is important to prevent their development. (Keyword) Angiotensin II Type 1 Receptor Blockers / Animals / Blood Pressure / Blotting, Western / Body Water / Carotid Arteries / Female / Humans / Hypertension / Imidazoles / Intracranial Aneurysm / Ligation / Ovariectomy / Rats / Rats, Sprague-Dawley / Renal Artery / Sodium / Sodium Chloride, Dietary / Sodium-Potassium-Exchanging ATPase / Tetrazoles / Up-Regulation / Water-Electrolyte Balance (Link to Publication Site) ● Publication site (DOI): 10.1161/HYPERTENSIONAHA.112.198762 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23045463 ● Search Scopus @ Elsevier (PMID): 23045463 ● Search Scopus @ Elsevier (DOI): 10.1161/HYPERTENSIONAHA.112.198762 (DOI: 10.1161/HYPERTENSIONAHA.112.198762, PubMed: 23045463)
47.	Yoshiteru Tada, Keiko T. Kitazato, Kenji Yagi, Kenji Shimada, Nobuhisa Matsushita, Tomoya Kinouchi, Yasuhisa Kanematsu, Junichiro Satomi, Teruyoshi Kageji and Shinji Nagahiro : Statins Promote the Growth of Experimentally Induced Cerebral Aneurysms in Estrogen-Deficient Rats, Stroke, Vol.42, No.8, 2286-2293, 2011. (Summary) The pathogenesis of cerebral aneurysms is linked to inflammation, degradation of the extracellular matrix, and vascular wall apoptosis. Statins exert pleiotropic effects on the vasculature, independent of their cholesterol-lowering properties. To explore the detailed pathogenesis of cerebral aneurysms, we examined their progression in a rat model and studied whether statins prevent their initiation and growth. Cerebral aneurysms were induced in female rats subjected to hypertension, increased hemodynamic stress, and estrogen deficiency. The development of aneurysm was assessed morphologically on corrosion casts. The effects of pravastatin (5, 25, or 50 mg/kg per day) and of simvastatin (5 mg/kg per day) on their aneurysms were studied. Human brain endothelial cells were also used to determine the effects of pravastatin. Pravastatin (5 mg/kg per day) reduced endothelial damage and inhibited aneurysm formation; there was an association with increased endothelial nitric oxide synthase (eNOS) levels and a decrease in human brain endothelial cell adhesion molecules. Unexpectedly, 25 mg/kg per day and 50 mg/kg per day pravastatin and 5 mg/kg per day simvastatin promoted aneurysmal growth, and high-dose pravastatin induced aneurysmal rupture. The deleterious effects exerted by these statins were associated with an increase in apoptotic caspase-3 levels and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive cells, suggesting that statins exert bidirectional effects. Our results provide the first evidence that cerebral aneurysm growth is partly associated with apoptosis and issue a warning that statins exert bidirectional effects on cerebral aneurysms. Additional intensive research is necessary to understand better their mechanisms and to identify patients in whom the administration of statins may elicit deleterious effects. (Keyword) Animals / Apoptosis / Brain / Cells, Cultured / Disease Models, Animal / Endothelial Cells / Estrogens / Female / Humans / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Hypertension / Intracranial Aneurysm / Nitric Oxide Synthase Type III / Pravastatin / Rats / Rats, Sprague-Dawley / Simvastatin (Link to Publication Site) ● Publication site (DOI): 10.1161/STROKEAHA.110.608034 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21737796 ● Search Scopus @ Elsevier (PMID): 21737796 ● Search Scopus @ Elsevier (DOI): 10.1161/STROKEAHA.110.608034 (DOI: 10.1161/STROKEAHA.110.608034, PubMed: 21737796)
48.	Kenji Shimada, Keiko T. Kitazato, Tomoya Kinouchi, Kenji Yagi, Yoshiteru Tada, Junichiro Satomi, Teruyoshi Kageji and Shinji Nagahiro : Activation of estrogen receptor- and of angiotensin-converting enzyme 2 suppresses ischemic brain damage in oophorectomized rats., Hypertension, Vol.57, No.6, 1161-1166, 2011. (Summary) Like the angiotensin II type 1 receptor blocker, endogenous estrogen (17-estradiol) is neuroprotective against cerebral ischemia; its effects are thought to be mediated by estrogen receptors (ERs). To verify the role of ERs and the brain renin-angiotensin system in estrogen-deficient rats with ischemia induced by middle cerebral artery occlusion, we compared rats subjected to oophorectomy (OVX(+)) with sham-oophorectomized rats (OVX(-)) and OVX(+) rats treated with 0.3 or 3.0 mg/kg of olmesartan for 2 weeks before middle cerebral artery occlusion. Independent of the blood pressure, the cortical infarct volume was larger in OVX(+) than in OVX(-) rats. It was smaller in olmesartan-pretreated OVX(+) rats. The expression of ER in the peri-infarct region was correlated with the reduction of cortical infarct but not that of ER or G protein-coupled estrogen receptor. Olmesartan prevented ER downregulation in the cortical peri-infarct area, without affecting ER or G protein-coupled estrogen receptor. Olmesartan also increased mRNA expression of angiotensin-converting enzyme 2, Bcl-2, and Bcl-xL and reduced angiotensin II and cleaved caspase 3. These effects were augmented by olmesartan and abolished by the ER inhibitor. In OVX(+) rats treated with the ER agonist alone, the infarct size was decreased, and the neuroprotective genes were upregulated. These findings suggest that the transactivation of neuroprotective genes and the reduction in brain angiotensin II are ER dependent and that this may augment neuroprotection together with an angiotensin II type 1 receptor blockade by olmesartan. We present the new insight that the activation of ER independent of estrogen contributes at least partly to limiting cerebral ischemic damage. (Keyword) Angiotensin II / Angiotensin II Type 1 Receptor Blockers / Animals / blood pressure / Blotting, Western / brain / Brain Ischemia / Caspase 3 / Dose-Response Relationship, Drug / Estrogen Receptor alpha / Female / gene expression / Imidazoles / immunohistochemistry / Ovariectomy / Peptidyl-Dipeptidase A / Pyrazoles / Rats / Rats, Wistar / Receptors, Angiotensin / Reverse Transcriptase Polymerase Chain Reaction / Tetrazoles / ras Proteins (Link to Publication Site) ● Publication site (DOI): 10.1161/HYPERTENSIONAHA.110.167650 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21536991 ● Search Scopus @ Elsevier (PMID): 21536991 ● Search Scopus @ Elsevier (DOI): 10.1161/HYPERTENSIONAHA.110.167650 (DOI: 10.1161/HYPERTENSIONAHA.110.167650, PubMed: 21536991)
49.	Yoshiteru Tada, Kenji Yagi, Keiko T. Kitazato, Tetsuya Tamura, Tomoya Kinouchi, Kenji Shimada, Nobuhisa Matsushita, Norio Nakajima, Junichiro Satomi, Teruyoshi Kageji and Shinji Nagahiro : Reduction of endothelial tight junction proteins is related to cerebral aneurysm formation in rats., Journal of Hypertension, Vol.28, No.9, 1883-1891, 2010. (Summary) OBJECTIVE: The formation of cerebral aneurysms is associated with endothelial damage and macrophage migration. Hypothesizing that the opening of tight junctions due to the disappearance of the tight junction proteins occludin and zona occludens-1 (ZO-1) in damaged endothelia allows macrophage migration, leading to cerebral aneurysm formation, we investigated the role of tight junction proteins. METHODS: The vascular wall of female rats subjected to hypertension, oophorectomy (OVX), and hemodynamic stress to induce cerebral aneurysms was evaluated morphologically, immunohistochemically, and by quantitative RT-PCR. We also assessed the regulation of tight junction proteins in human brain endothelial cells (HBECs). RESULTS: In the very early stage before aneurysm formation, the expression of occludin and ZO-1 was reduced in injured endothelial cell junctions exhibiting gaps. In the course of aneurysmal progression their reduction progressed and was correlated with macrophage migration. In hypertension along with OVX rats we observed an increase in angiotensin II and the degradation molecules matrix metalloproteinase-9 (MMP-9), nicotinamide-adenine dinucleotide phosphate oxidases and monocyte chemoattractant protein-1. The mineralocorticoid receptor blocker eplerenone increased occludin and ZO-1 expression; this was associated with a reduction in angiotensin II and the degradation molecules and resulted in the inhibition of macrophage exudation and aneurysm formation. In HBECs, occludin and ZO-1 downregulation by angiotensin II and estrogen deficiency was reversed by eplerenone, the MMP inhibitor SB3CT, and apocynin. Our results suggest that macrophage migration is associated with the reduction in tight junction proteins induced by the degradation molecules. CONCLUSION: In rats, the destruction of tight junctions may facilitate macrophage migration and cerebral-aneurysm formation. (Link to Publication Site) ● Publication site (DOI): 10.1097/HJH;0b013e32833c2273 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 20577123 ● Search Scopus @ Elsevier (PMID): 20577123 ● Search Scopus @ Elsevier (DOI): 10.1097/HJH;0b013e32833c2273 (DOI: 10.1097/HJH;0b013e32833c2273, PubMed: 20577123)
50.	Yoshiteru Tada, Keiko T. Kitazato, Tetsuya Tamura, Kenji Yagi, Kenji Shimada, Tomoya Kinouchi, Junichiro Satomi, Shinji Nagahiro and Shinji Nagahiro : Role of mineralocorticoid receptor on experimental cerebral aneurysms in rats., Hypertension, Vol.54, No.3, 552-557, 2009. (Summary) Activation of the renin-angiotensin (Ang)-aldosterone system is involved in the pathology of vascular diseases. Although the blockade of the mineralocorticoid receptor protects against vascular diseases, its role in cerebral aneurysms remains to be elucidated. We treated female rats subjected to renal hypertension, increased hemodynamic stress, and estrogen deficiency for 3 months with the mineralocorticoid receptor blocker eplerenone (30 or 100 mg/kg per day) or vehicle (vehicle control). Eplerenone reduced the incidence of cerebral aneurysms and saline intake without lowering of the blood pressure. In the aneurysmal wall, the production of Ang II and nitrotyrosine was increased. The mRNA levels of Ang-converting enzyme 1 and NADPH oxidase subunits NOX4, Rac1, monocyte chemoattractant protein 1, and matrix metalloproteinase 9 were increased. Eplerenone brought about a reduction in these molecules, suggesting that mineralocorticoid receptor blockade suppresses cerebral aneurysm formation by inhibiting oxidative stress, inflammatory factors, local renin-Ang system activation, and saline intake. Other female rats implanted with pellets of the mineralocorticoid receptor agonist deoxycorticosterone acetate manifested a high incidence of cerebral aneurysm formation and the upregulation of molecules related to oxidative stress, inflammatory factors, and the local renin-Ang system; their saline intake was increased. We demonstrate that mineralocorticoid receptor activation at least partly contributes to the pathogenesis of cerebral aneurysms. (Keyword) Aldosterone / Angiotensin II / Animals / blood pressure / Cerebral Arteries / Chemokine CCL2 / Female / gene expression / Hypertension, Renal / immunohistochemistry / Intracranial Aneurysm / Mineralocorticoid Receptor Antagonists / NADPH Oxidase / Ovariectomy / oxidative stress / Peptidyl-Dipeptidase A / RNA, Messenger / Rats / Rats, Sprague-Dawley / Receptors, Mineralocorticoid / Renin-angiotensin System / Reverse Transcriptase Polymerase Chain Reaction / Spironolactone / Tyrosine (Link to Publication Site) ● Publication site (DOI): 10.1161/HYPERTENSIONAHA.109.134130 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 19620512 ● Search Scopus @ Elsevier (PMID): 19620512 ● Search Scopus @ Elsevier (DOI): 10.1161/HYPERTENSIONAHA.109.134130 (DOI: 10.1161/HYPERTENSIONAHA.109.134130, PubMed: 19620512)
51.	Kenji Yagi, Keiko T. Kitazato, Masaaki Uno, Yoshiteru Tada, Tomoya Kinouchi, Kenji Shimada and Shinji Nagahiro : Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasmininogen activator, Stroke, Vol.40, No.2, 626-631, 2009. (Summary) Intracerebral hemorrhage, induced by recombinant tissue plasminogen activator (rtPA) in ischemic stroke, is attributable to the increased activity of matrix metalloproteinase-9 (MMP-9). Patients with acute infarct benefit from the neuroprotective drug edaravone, a free radical scavenger. We examined the mechanisms by which edaravone may help to suppress rtPA-induced brain hemorrhage. Male Wistar rats weighing 250 to 280 g were subjected to 3-hour transient middle cerebral artery occlusion (MCAO) and divided randomly into 3 groups. Immediately after reperfusion, 1 group was intravenously injected with 10 mg/kg rtPA, another with rtPA plus 3 mg/kg edaravone, and the 3rd group received no treatment. We assessed the hemorrhage volume and the activity of MMP-9 in the brain 24 hours postischemia. We also studied the activity of MMP-9, its mRNA expression, and nuclear factor-kappa B (NF-kappaB) activity in rtPA-stimulated human microvascular endothelial cells (HBECs). The degree of hemorrhage and the level of endothelial cell-derived MMP-9 were elevated in rats treated with rtPA alone and attenuated in rats treated with rtPA plus edaravone. In rtPA-stimulated HBECs, edaravone suppressed the activity and mRNA expression of MMP-9 in a dose-dependent manner. Edaravone also inhibited NF-kappaB activation. We demonstrate that edaravone inhibits rtPA-induced cerebral hemorrhage in the ischemic brain of rats via the inhibition of MMP-9 expression in vivo, which is substantiated by inhibition of MMP-9 expression and NF-kappaB activation in HBECs. Edaravone may render thrombolytic therapy safer for the administration of rtPA in patients with ischemic stroke. (Keyword) Animals / Antipyrine / blood pressure / Blotting, Western / Brain Ischemia / Cells, Cultured / Cerebral Hemorrhage / Dose-Response Relationship, Drug / Endothelial Cells / Free Radical Scavengers / immunohistochemistry / Infarction, Middle Cerebral Artery / Male / Matrix Metalloproteinase 9 / Middle Cerebral Artery / NF-kappa B / RNA, Messenger / Rats / Rats, Wistar / Reperfusion Injury / Reverse Transcriptase Polymerase Chain Reaction / Tissue Plasminogen Activator (Link to Publication Site) ● Publication site (DOI): 10.1161/STROKEAHA.108.520262 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 19095969 ● Search Scopus @ Elsevier (PMID): 19095969 ● Search Scopus @ Elsevier (DOI): 10.1161/STROKEAHA.108.520262 (DOI: 10.1161/STROKEAHA.108.520262, PubMed: 19095969)

Academic Paper (Unrefereed Paper):

1.	Izumi Yamaguchi, Yasuhisa Kanematsu, Kenji Shimada, Nobuaki Yamamoto, Masaaki Korai, Kazuhisa Miyake, Takeshi Miyamoto, Shu Sogabe, Eiji Shikata, Manabu Ishihara, Yuki Yamamoto, Kazutaka KURODA and Yasushi Takagi : Evaluation of Serial Intra-Arterial Indocyanine Green Videoangiography in the Surgical Treatment of Cranial and Craniocervical Junction Arteriovenous Fistulae: A Case Series, Operative Neurosurgery, Vol.25, No.3, 292-300, 2023. (Summary) Intravenous indocyanine green (IV-ICG) videoangiography is commonly performed to detect blood flow in the microscopic view. However, intra-arterial ICG (IA-ICG) videoangiography provides high-contrast imaging, repeatability within a short period of time, and clear-cut separation of the arterial and venous phases compared with IV-ICG. These features are useful for detecting retrograde venous drainage (RVD) and shunt occlusion in arteriovenous fistulae (AVF) surgery. This study aimed to investigate whether IA-ICG videoangiography can be repeatable within a short period of time and be useful for detecting RVD and shunt occlusion in cranial- and craniocervical junction (CCJ)-AVF surgery. Between January 2012 and December 2022, 50 patients were treated with endovascular or surgical intervention for cranial- and CCJ-AVF at Tokushima University Hospital. Of these, 5 patients (6 lesions) underwent open surgery with IA-ICG videoangiography in a hybrid operating room. We analyzed the data of these 5 patients (6 lesions). There were 4/patient (median, range 2-12) and 3.5/lesion (median, range 2-10) intraoperative IA-ICG runs. IA-ICG videoangiography detected RVD in all patients. Clearance of IA-ICG-induced fluorescence was achieved within 30 seconds in all patients at each region of interest. After the disconnection of the fistulae, IA-ICG videoangiography and intraoperative digital subtraction angiography (DSA) confirmed the disappearance of RVD in all patients. There were no complications associated with IA-ICG videoangiography. This study showed that IA-ICG videoangiography is repeatable within a short period of time before and after obliteration and can be useful for detecting RVD and shunt occlusion in cranial- and CCJ-AVF surgery. IA-ICG videoangiography also allows intraoperative DSA studies in a hybrid operating room. Considering the recent advancements in hybrid operating rooms, combining IA-ICG videoangiography with intraoperative DSA is a useful strategy for cranial- and CCJ-AVF surgery. (Keyword) Humans / Indocyanine Green / Coloring Agents / Neurosurgical Procedures / Vascular Surgical Procedures / Arteries (Link to Publication Site) ● Publication site (DOI): 10.1227/ons.0000000000000796 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37345942 ● Summary page in Scopus @ Elsevier: 2-s2.0-85168222953 (DOI: 10.1227/ons.0000000000000796, PubMed: 37345942, Elsevier: Scopus)

Proceeding of International Conference:

1.	Yoshiteru Tada, Toshitaka Fujihara, Kenji Shimada, Nobuaki Yamamoto, Hiroki Yamazaki, Yuishin Izumi, Masafumi Harada, Yasuhisa Kanematsu and Yasushi Takagi : Peri-ictal normal arterial spin labeling imaging in patients with seizures, 13 回アジア・オセアニアてんかん学会(13th AOEC), Jun. 2021.
2.	Tadashi Yamaguchi, Keiko T Kitazato, Eiji Shikata, Idumi Yamaguchi, Takeshi Miyamoto, Masaaki Korai, Kenji Shimada, Yoshiteru Tada, Yasuhisa Kanematsu and Yasushi Takagi : Pro-inflammatory response promoted by Porphyromonas gingivalis lipopolysaccharide enhances the rupture of experimental intracranial aneurysms., Brain and Brain PET2019, Yokohama, Jul. 2019.
3.	Yuki Yamamoto, Nobuaki Yamamoto, K Kuroda, Yasuhisa Kanematsu, Masaaki Korai, Kenji Shimada, Yuishin Izumi and Yasushi Takagi : High White Blood Cell Count is a Risk Factor for Contrast-Induced Nephropathy following Mechanical Thrombectomy, The 5th European Stroke Organization Conference, ESOC 2019, Milan, May 2019.
4.	Nobuaki Yamamoto, Yuki Yamamoto, Masaaki Korai, Kenji Shimada, Yasuhisa Kanematsu, Yuishin Izumi, Yasushi Takagi and Ryuji Kaji : Hyperintense Signals on Arterial Spin-Labeled Imaging as a predictor for favorable outcome after Late Time Window Thrombectomy, The 5th European Stroke Organization Conference, ESOC 2019, Milan, May 2019.
5.	Tadashi Yamaguchi, Takeshi Miyamoto, Masaaki Korai, Kenji Shimada, Yoshiteru Tada, Yasuhisa Kanematsu, Junichiro Satomi, Shinji Nagahiro and Yasushi Takagi : Estrogen deficiency activates inflammasome in a rat model of intracranial aneurysms, 11th World Stroke Congress 2018, Montreal, Oct. 2018.
6.	Takeshi Miyamoto, Yoshiteru Tada, Kenji Shimada, Kenji Yagi, Masaaki Korai, Hidetsugu Maekawa, Tadashi Yamaguchi, Syotaro Soshioka, Tomoya Kinouchi, Yasuhisa Kanematsu, Junichiro Satomi and Shinji Nagahiro : Pro-inflammatory Response Elicited by Porphyromonas Gingivalis Lipopolysaccharide Exacerbates the Rupture of Experimental Cerebral Aneurysms, International Stroke Conference 2017, Houston, Feb. 2017.
7.	Takeshi Miyamoto, Keiko Kitazato, Hidetsugu Maekawa, Tadashi Yamaguchi, Kenji Shimada, Kenji Yagi, Yoshiteru Tada, Yoshitaka Kurashiki, syotaro Yoshioka, Yasuhisa Kanematsu, Junichiro Satomi and Shinji Nagahiro : Porphyromonas gingivalis lipopolysaccharide enhances the rupture of intracranial aneurysms in rats, 25th European Stroke Conference, Apr. 2016.
8.	Yoshitaka Kurashiki, Keiko Kitazato, Kenji Shimada, Kenji Yagi, Yoshiteru Tada, Tomoya Kinouchi, Manabu Sumiyoshi, Takeshi Miyamoto, Tadashi Yamaguchi, Junichiro Satomi, Yoshihiro Uto and Shinji Nagahiro : Activation of M2 macrophages in the late phase of cerebral ischemia may contribute to phagocytosis of infarct area and neurogenesis, 25th European Stroke Conference, Apr. 2016.
9.	Takeshi Miyamoto, Masaaki Korai, David K. Kung, Keiko K. Kitazato, Kenji Shimada, Kenji Yagi, Yoshiteru Tada, Yoshitaka Kurashiki, Kazuyuki Kuwayama, Junichiro Satomi and Shinji Nagahiro : Hemodynamic changes elicit the formation and rupture of experimental cerebral aneurysms, International stroke conference, Nashville, Feb. 2015.
10.	Masaaki Korai, Kenji Shimada and Tomoki Hashimoto : Roles of macrophage PPARγ on intracranial aneurysmal rupture, International stroke conference, Nashville, Feb. 2015.
11.	Yoshitaka Kurashiki, Kenji Shimada, Kenji Yagi, Yoshiteru Tada, Manabu Sumiyoshi, 宮本健志, Junichiro Satomi, Teruyoshi Kageji and Shinji Nagahiro : Predominant Activation of M2 Macrophages by Group-specific Component Protein-derived Macrophage Activating, INTERNATIONAL STROKE CONFERENCE 2015, Feb. 2015.
12.	Masaaki Korai, Kenji Shimada, Yoshiteru Tada and Shinji Nagahiro : INTERNATIONAL STROKE CONFERENCE 2015 Roles of Macrophage PPAR on Intracranial Aneurysmal Rupture, INTERNATIONAL STROKE CONFERENCE 2015, Feb. 2015.
13.	宮本健志, Masaaki Korai, Kenji Shimada, Kenji Yagi, Yoshiteru Tada, Yoshitaka Kurashiki, Kazuyuki Kuwayama, Junichiro Satomi and Shinji Nagahiro : Hemodynamic Changes May Be Partly Attributable To The Formation And Rupture Of Aneurysms In A Rat Model, INTERNATIONAL STROKE CONFERENCE 2015, Feb. 2015.
14.	Yoshitaka Kurashiki, K.T Kitazato, Kung K David, Kenji Shimada, Kenji Yagi, Yoshiteru Tada, Nobuhisa Matsushita, Manabu Sumiyoshi, Junichiro Satomi, Y Uto and Shinji Nagahiro : Effects of the immunostimulant GcMAF in cerebral ischemia, Congress Of Neurological Surgeons 2013 Annual Meeting, San Francisco, Oct. 2013.
15.	Masaaki Korai, David K Kung, K.T Kitazato, Nobuhisa Matsushita, Yoshiteru Tada, Kenji Yagi, Kenji Shimada, Yasuhisa Kanematsu, Junichiro Satomi and Shinji Nagahiro : Role of hyperhomocysteinemia in the development of intracranial aneurysms, Congress Of Neurological Surgeons 2013 Annual Meeting, San Francisco, Oct. 2013.
16.	Tomoya Kinouchi, Yoshitaka Kurashiki, 北里慶子, Kenji Shimada, Kenji Yagi, Yoshiteru Tada, Nobuhisa Matsushita, Manabu Sumiyoshi, Junichiro Satomi, Masataka Sata and Shinji Nagahiro : Post-stroke PPAR activation promotes the proliferation and differentiation of innate- and bone marrow-derived stem cells insubventricular zone, leading to vasogenesis and neurogenesis in cortex, International STROKE Conference 2013, Honolulu, Feb. 2013.
17.	Nobuhisa Matsushita, Keiko T. Kitazato, Kenji Shimada, Tomoya Kinouchi, Manabu Sumiyoshi, Yasuhisa Kanematsu, Junichiro Satomi and Shinji Nagahiro : Impact of high salt intake on the formation and growth of cerebral aneurysm, The 5th International Aldosterone Forum in Japan, Tokyo, May 2012.
18.	Masaaki Korai, Keiko T. Kitazato, Tomoya Kinouchi, Kenji Shimada, Nobuhisa Matsushita, Manabu Sumiyoshi, Yasuhisa Kanematsu, Junichiro Satomi, Teruyoshi Kageji and Shinji Nagahiro : Activation of Nuclear Receptors on Neuroprotection after Experimental Cerebral Ischemia in Female Rats, American Association of Neurologial Surgeons Annual Scientific Meeting, Miami, Apr. 2012.
19.	Nobuhisa Matsushita, Keiko T. Kitazato, Kenji Shimada, Tomoya Kinouchi, Yasuhisa Kanematsu, Junichiro Satomi and Shinji Nagahiro : Influence of sodium retention on the formation of cerebral aneurysm, American Association of Neurologial Surgeons Annual Scientific Meeting, Miami, Apr. 2012.
20.	Keiko T. Kitazato, Yoshiteru Tada, Tetsuya Tamura, Kenji Yagi, Kenji Shimada, Nobuhisa Matsushita, Tomoya Kinouchi, Yasuhisa Kanematsu, Junichiro Satomi, Teruyoshi Kageji and Shinji Nagahiro : Vascular Mineralcorticoid Receptor Antagonism Combined with A Decrease in Salt-intake By Eplerenone Inhibits Cerebral Aneurysm without Affecting Blood Pressure, International Stroke Conference 2011, LosAngels, Feb. 2012.
21.	KT Kitazato, Yoshiteru Tada, Tetsuya Tamura, Kenji Yagi, Kenji Shimada, Nobuhisa Matsushita, Tomoya Kinouchi, Yasuhisa Kanematsu, Junichiro Satomi, Teruyoshi Kageji and Shinji Nagahiro : Vascular mineralcorticoid receptor antagonism combined with a decrease in salt-intake by eplerenone inhibits cerebral aneurysm without affecting blood pressure, International Stroke Conference 2011, Los Angeles, Oct. 2011.
22.	KT Kitazato, Tomoya Kinouchi, Kenji Shimada, Yoshiteru Tada, Nobuhisa Matsushita, Manabu Sumiyoshi, Yasuhisa Kanematsu, Junichiro Satomi, Teruyoshi Kageji and Shinji Nagahiro : Role of Nuclear receptors on neuroprotection after experimental cerebral ischemia in female rats, 115th International Symposium on Cerebral Blood Flow Metabolism and Function, Barcelona, May 2011.
23.	Manabu Sumiyoshi, Tomoya Kinouchi, T Tsutsumi, Keiko T. Kitazato, Kenji Shimada, Nobuhisa Matsushita, Yasuhisa Kanematsu, Junichiro Satomi and Shinji Nagahiro : High salt intake under hypoestrogenecity deteriorates ischemic brain damage without affecting blood pressure, 115th International Symposium on Cerebral Blood Flow,Metabolism,and Function, Barcelona, May 2011.
24.	Kenji Shimada, Keiko T. Kitazato, Tomoya Kinouchi, Kenji Yagi, Yoshiteru Tada, Junichiro Satomi, Teruyoshi Kageji and Shinji Nagahiro : Activation of estrogen receptor a and of ace2 suppresses ischemic brain damage in oophorectomized rats, 115th International Symposium on Cerebral Blood Flow,Metabolism,and Function, Barcelona, May 2011.
25.	Kenji Shimada, Keiko T. Kitazato, Tomoya Kinouchi, Kenji Yagi, Yoshiteru Tada, Junichiro Satomi, Teruyoshi Kageji and Shinji Nagahiro : Up-regulation of estrogen receptor alpha with down-regulation of the brain renin-angiotensin system by olmesartan contributes to neuroprotection against cerebral infarction in estrogen-deficient rats, International Stroke Conference 2011, Los Angeles, Feb. 2011.
26.	Kenji Shimada, Keiko T. Kitazato, Tomoya Kinouchi, Kenji Yagi, Yoshiteru Tada, Junichiro Satomi, Teruyoshi Kageji and Shinji Nagahiro : Activation of estrogen receptor and inhibition of local renin angiotensin system against cerebral ischenmia in oophorectomized rats, The 1st World Forum on Cerebral Blood Flow Metabolism & Function, Kyoto, Oct. 2010.
27.	Kenji Shimada, Tomoya Kinouchi, KT Kitazato, Yoshiteru Tada, Kenji Yagi, Teruyoshi Kageji and Shinji Nagahiro : Role of Estrogen receptors in cerebral ischemia in female rats; Contribution of angiotensintype 1 receptor blocker, XIV World Congress of Neurological Surgery, Boston, Aug. 2009.
28.	Tomoya Kinouchi, Keiko T. Kitazato, Kenji Yagi, Kenji Shimada, Yoshiteru Tada, Junichiro Satomi, Teruyoshi Kageji and Shinji Nagahiro : Pioglitazone promotes neuroprotection through the activation of STAT3 against cerebral ischemia in female rats, XIV World Congress of Neurological Surgery, Boston, Aug. 2009.
29.	Yoshiteru Tada, Keiko T. Kitazato, Tetsuya Tamura, Kenji Yagi, Kenji Shimada, Tomoya Kinouchi, Nobuhisa Matsushita, Junichiro Satomi and Shinji Nagahiro : Eplerenone Suppresses the Progression of Experimentally-induced Cerebral Aneurysms in Rats, XIV World Congress of Neurological Surgery, Boston, Aug. 2009.
30.	Yoshiteru Tada, Keiko T. Kitazato, Tetsuya Tamura, Kenji Yagi, Kenji Shimada, Tomoya Kinouchi, Junichiro Satomi and Shinji Nagahiro : Role of mineralocorticoid receptor on experimental cerebral aneurysms in rats, The 6th International Intracranial Stent Meeting 2009, Sendai, Aug. 2009.

Proceeding of Domestic Conference:

1.	Kenji Shimada and Yasushi Takagi : Chronological change of treatment indication and outcome of cerebral arteriovenous malformation in our institute, 日本脳神経外科学会第83回学術総会, Oct. 2024.
2.	Masaaki Korai, Takeshi Miyamoto, Manabu Ishihara, Kenji Shimada and Yasushi Takagi : Characteristics of cases requiring retreatment after coil embolization for ruptured aneurysm, 日本脳神経外科学会第83回学術総会, Oct. 2024.
3.	Takeshi Miyamoto, Manabu Ishihara, Masaaki Korai, Kenji Shimada and Yasushi Takagi : Arterial spin-labeling changes after revascularization surgery for Moyamoya disease, 日本脳神経外科学会第83回学術総会, Oct. 2024.
4.	Yoshiteru Tada, Toshitaka Fujihara, Masaaki Korai, Takeshi Miyamoto, Kenji Shimada and Yasushi Takagi : Outcome of nonconvulsive status epilepticus in patients with acute subarachnoid hemorrhage, 日本脳神経外科学会第83回学術総会, Oct. 2024.
5.	富永洋介, Masaaki Korai, Takeshi Miyamoto, Yuki Yamamoto, Nobuaki Yamamoto, Kenji Shimada and Yasushi Takagi : 脳梗塞で発症した大型部分血栓化後大脳動脈瘤の一例, 第33回NPO法人日本脳神経血管内治療学会中国四国地方会, Sep. 2024.
6.	Kazuma Sahara, Kenji Shimada, HABOSHI Tatsuya, Izumi Yamaguchi, Shu Sogabe, Masaaki Korai, Nobuaki Yamamoto, Yasuhisa Kanematsu and Yasushi Takagi : A case of external carotid artery aneurysm considered as an embolic source of cerebral infarction, 第97回日本脳神経外科学会中国四国支部会, Apr. 2024.
7.	Yasuhisa Kanematsu, Yuki Kanazawa, Kenji Shimada, Masaaki Korai, Shu Sogabe, Manabu Ishihara, Izumi Yamaguchi, HABOSHI Tatsuya, Nobuaki Yamamoto, KURODA Kazutaka, Masafumi Harada and Yasushi Takagi : Chemical exchange saturation transfer MRI for carotid plaque imaging, STROKE 2024, Mar. 2024.
8.	Kenji Shimada, Izumi Yamaguchi, Takeshi Miyamoto, Shu Sogabe, Masaaki Korai, Nobuaki Yamamoto, 花岡真実, Yasuhisa Kanematsu, Kazuhito Matsuzaki, Koichi Satoh and Yasushi Takagi : Difference of clinical features between osseous and non-osseous arteriovenous fistulas of cavernous sinus, STROKE 2024, Mar. 2024.
9.	Masaaki Korai, Noriya Enomoto, HABOSHI Tatsuya, Izumi Yamaguchi, Shu Sogabe, Kenji Shimada, KURODA Kazutaka, Nobuaki Yamamoto, Yasuhisa Kanematsu, Shunji Matsubara, Koichi Satoh and Yasushi Takagi : Incidence and temporal angiographic changes in venous drainage of convexity dural arteriovenous fistula, STROKE 2024, Mar. 2024.
10.	Masaaki Korai, Noriya Enomoto, Izumi Yamaguchi, Shu Sogabe, Kenji Shimada, Kazutaka KURODA, Nobuaki Yamamoto, Yasuhisa Kanematsu, Shunji Matsubara, Koichi Satoh and Yasushi Takagi : Incidence and temporal angiographic changes in venous drainage of convexity dural arteriovenous fistula, 第39回日本脳神経血管内治療学会学術集会, Nov. 2023.
11.	Kenji Shimada, Izumi Yamaguchi, Takeshi Miyamoto, Shu Sogabe, Masaaki Korai, Nobuaki Yamamoto, 花岡真美, Yasuhisa Kanematsu, Kazuhito Matsuzaki, Koichi Satoh and Yasushi Takagi : 骨内シャントの有無による海綿静脈洞部硬膜動静脈瘻の臨床的特徴の違いについて, 第39回日本脳神経血管内治療学会学術集会, Nov. 2023.
12.	Yasuhisa Kanematsu, Tatsuya HABOSHI, Izumi Yamaguchi, Manabu Ishihara, Shu Sogabe, Masaaki Korai, Kenji Shimada, Kazutaka KURODA, Nobuaki Yamamoto and Yasushi Takagi : Implementing action utilizing ICT for acute stroke in the local area., 第39回日本脳神経血管内治療学会学術集会, Nov. 2023.
13.	Yasuhisa Kanematsu, 羽星辰哉, Izumi Yamaguchi, Manabu Ishihara, Shu Sogabe, Masaaki Korai, Kenji Shimada and Yasushi Takagi : 循環器病推進計画の中での地方におけるICTを活用した急性期脳卒中診療の取り組み, Oct. 2023.
14.	Kenji Shimada, Izumi Yamaguchi, Takeshi Miyamoto, Shu Sogabe, Masaaki Korai, Nobuaki Yamamoto, 花岡真実, Yasuhisa Kanematsu, Kazuhito Matsuzaki, Koichi Satoh and Yasushi Takagi : 骨内シャントの有無による海綿静脈洞部硬膜動静脈瘻の臨床的特徴の違いについて, 日本脳神経外科学会第82回学術集会, Oct. 2023.
15.	Shu Sogabe, Yasuhisa Kanematsu, Izumi Yamaguchi, Nobuaki Yamamoto, Kenji Shimada and Yasushi Takagi : もやもや病に合併した頭蓋内内頚動脈閉塞に対して再開通療法をおこなった1例, 脳血管内治療ブラッシュアップセミナー2023, Jul. 2023.
16.	Nobuaki Yamamoto, KURODA Kazutaka, Yuki Yamamoto, Yuishin Izumi, Shu Sogabe, Masaaki Korai, Kenji Shimada, Yasuhisa Kanematsu and Yasushi Takagi : First pass TICI2B患者の追加治療における意義, 第64回日本神経学会学術大会, May 2023.
17.	Yuki Yamamoto, Nobuaki Yamamoto, KURODA Kazutaka, Tomohiro Matsuda, Kenji Shimada, Yasuhisa Kanematsu, Yasushi Takagi and Yuishin Izumi : 頸動脈浮遊血栓に対する，ステントトリーバーによる血栓回収とCASの併用, 第64回日本神経学会学術大会, May 2023.
18.	Kenji Shimada, Kazuhisa Miyake, Izumi Yamaguchi, Takeshi Miyamoto, Shu Sogabe, Yasuhisa Kanematsu and Yasushi Takagi : VM摘出術における3D multimodal fusion imageとindocyanine green動注による術中videoangiography併用の有用性, 第32回脳神経外科手術と機器学会(CNTT2023), Apr. 2023.
19.	Taku Matsuda, Nori Sato, 梅村公子, Kenji Shimada, Yasuhisa Kanematsu and Yasushi Takagi : 脳卒中後の深部感覚障害による歩行障害に対してHALリハビリテーションを行い歩容の改善が得られた一例, STROKE2023, Mar. 2023.
20.	Masaaki Korai, Yasuhisa Kanematsu, Kenji Shimada, Nobuaki Yamamoto, Shu Sogabe, Manabu Ishihara, Izumi Yamaguchi, Yuki Yamamoto, 黒田一駿 and Yasushi Takagi : 当院での急性期脳底動脈閉塞に対する血管内治療成績, 第48回日本脳卒中学会学術集会, Mar. 2023.
21.	Yasuhisa Kanematsu, Izumi Yamaguchi, Manabu Ishihara, Shu Sogabe, Takeshi Miyamoto, Masaaki Korai, Kenji Shimada, KURODA Kazutaka, Nobuaki Yamamoto, Yuki Yamamoto, Yuishin Izumi and Yasushi Takagi : 徳島県循環器病推進計画の中での急性期脳卒中診療の取り組み, STROKE2023, Mar. 2023.
22.	Kenji Shimada : 当院のおけるTentorial dural arteriovenous fisutulaの症例検討, 第52回日本脳卒中の外科学会学術集会, Mar. 2023.
23.	Shu Sogabe, Takeshi Miyamoto, Izumi Yamaguchi, Masaaki Korai, Kenji Shimada, Yasuhisa Kanematsu, Yuki Yamamoto, Nobuaki Yamamoto, Masafumi Harada, Yuishin Izumi and Yasushi Takagi : 当院での低ASPECTS症例の拡散強調画像に対するRAPIDを用いた後方視的定量評価, 第48回日本脳卒中学会学術集会, Mar. 2023.
24.	KURODA Kazutaka, Yuki Yamamoto, Nobuaki Yamamoto, Tomohiro Matsuda, 板東康司, Izumi Yamaguchi, Masaaki Korai, Kenji Shimada, Yasuhisa Kanematsu, Yuishin Izumi and Yasushi Takagi : 広範囲シャントを伴った横静脈洞部硬膜動静脈瘻に対して血管内治療を行った1例, 第112回日本神経学会中国・四国地方会, Dec. 2022.
25.	松田拓, Hiroshi Kagusa, Izumi Yamaguchi, Shu Sogabe, Kenji Shimada, Yasuhisa Kanematsu, Yasushi Takagi, 近藤心, Nori Sato, 梅村公子 and Tetsuya Matsuura : 急性期脳卒中患者におけるロボットスーツHALの即時効果についての検討, Shikoku Acta Medica, Vol.78, No.5-6, 245, Dec. 2022.
26.	Shu Sogabe, Takeshi Miyamoto, Izumi Yamaguchi, Masaaki Korai, Kenji Shimada, Yasuhisa Kanematsu, Yuki Yamamoto, Nobuaki Yamamoto, Masafumi Harada, Yuishin Izumi, Yuishin Izumi and Yasushi Takagi : 当院の主幹動脈閉塞低ASPECT症例の拡散強調画像に対するRAPIDでの後方視的定量評価, 第38回NPO法人日本脳神経血管内治療学会学術集会, Nov. 2022.
27.	Yuki Yamamoto, Yasuhisa Kanematsu, Nobuaki Yamamoto, KURODA Kazutaka, Izumi Yamaguchi, Shu Sogabe, Masaaki Korai, Kenji Shimada, Yasushi Takagi and Yuishin Izumi : 地方都市における救急医療連携アプリケーションを用いたLVO診断スケールの活用, 第38回NPO法人日本脳神経血管内治療学会学術集会, Nov. 2022.
28.	Nobuaki Yamamoto, KURODA Kazutaka, Yuki Yamamoto, Izumi Yamaguchi, Shu Sogabe, Kenji Shimada, Yasuhisa Kanematsu, Yuishin Izumi and Yasushi Takagi : 病院前スケール，iSchemaView RAPID導入前後の比較検討, 第38回NPO法人日本脳神経血管内治療学会学術集会, Nov. 2022.
29.	Nobuaki Yamamoto, Yuki Yamamoto, KURODA Kazutaka, Izumi Yamaguchi, Shu Sogabe, Masaaki Kohrai, Kenji Shimada, Yasuhisa Kanematsu, Yasushi Takagi and Yuishin Izumi : 9Fr long sheathを用いた巨大血栓によるLVO治療例, 第38回NPO法人日本脳神経血管内治療学会学術集会, Nov. 2022.
30.	Masaaki Korai, Yasuhisa Kanematsu, Kenji Shimada, Nobuaki Yamamoto, Shu Sogabe, Manabu Ishihara, Izumi Yamaguchi, Yuki Yamamoto, KURODA Kazutaka and Yasushi Takagi : Endovascular treatment outcome of acute basilar artery occlusion. -single center series-, 第38回NPO法人日本脳神経血管内治療学会学術集会, Nov. 2022.
31.	Masaaki Korai, Tomoki Hashimoto, Takeshi Miyamoto, Keiko Kitazato, Eiji Shikata, Tadashi Yamaguchi, Kenji Shimada, Yoshiteru Tada, Yasuhisa Kanematsu and Yasushi Takagi : Neutrophil extracellular traps promote rupture of intracranial aneurysms, 日本脳神経外科学会第81回学術総会, Sep. 2022.
32.	Shu Sogabe, Takeshi Miyamoto, Izumi Yamaguchi, Masaaki Korai, Kenji Shimada, Yasuhisa Kanematsu, Yuki Yamamoto, Nobuaki Yamamoto, Masafumi Harada, Yuishin Izumi and Yasushi Takagi : Quantitative retrospective evaluation using RAPID for diffusion-weighted images of large vessel occlusion-low ASPECT cases in our hospital, 日本脳神経外科学会第81回学術総会, Sep. 2022.
33.	Yasuhisa Kanematsu, Izumi Yamaguchi, Manabu Ishihara, Shu Sogabe, Masaaki Korai, Yoshiteru Tada, Kenji Shimada, KURODA Kazutaka, Yuki Yamamoto, Nobuaki Yamamoto, Kenta Satou, Yoshimitsu Shimatani, 亘雄也, Tetsuya Tamura, 新野清人 and Yasushi Takagi : Management for acute stroke in comprehensive medical zone in Tokushima, 日本脳神経外科学会第81回学術総会, Sep. 2022.
34.	Yoshiteru Tada, Toshitaka Fujihara, Kenji Shimada, Yasuhisa Kanematsu and Yasushi Takagi : Seizure types associated with finding of arterial spin labeling and diffusion-weighted imaging, 第55回日本てんかん学会学術集会, Sep. 2022.
35.	Yuki Yamamoto, Yasuhisa Kanematsu, Nobuaki Yamamoto, KURODA Kazutaka, Izumi Yamaguchi, Shu Sogabe, Masaaki Korai, Kenji Shimada, Yasushi Takagi and Yuishin Izumi : 徳島市におけるアプリケーションを用いたLVO診断スケールの活用(FAST-ED Tokushima), 第24回中国四国脳卒中研究会, Sep. 2022.
36.	Yasuhisa Kanematsu, Izumi Yamaguchi, Manabu Ishihara, Shu Sogabe, Takeshi Miyamoto, Masaaki Korai, Kenji Shimada, KURODA Kazutaka, Yuki Yamamoto, Nobuaki Yamamoto, Yuishin Izumi and Yasushi Takagi : 徳島県循環器病推進計画の中での急性期脳卒中診療の取り組み, 徳島医学会学術集会, Jul. 2022.
37.	Kenji Shimada, Kazuhisa Miyake, Izumi Yamaguchi, Takeshi Miyamoto, Shu Sogabe, Yasuhisa Kanematsu and Yasushi Takagi : Efficacy of combination use of 3D multimodal fusion image and intra-arterial ICG videoangiography in cerebral AVM surgery, 第51回日本脳卒中の外科学会学術集会, Mar. 2022.
38.	Shu Sogabe, Yasuhisa Kanematsu, Izumi Yamaguchi, Eiji Shikata, Takeshi Miyamoto, Kenji Shimada, Yuki Yamamoto, Nobuaki Yamamoto and Yasushi Takagi : Results of CAS with overlapped open-cell and closed-cell stent, STROKE2022, Mar. 2022.
39.	Yasuhisa Kanematsu, Toshitaka Fujihara, Kenji Shimada, Yoshiteru Tada and Yasushi Takagi : 外傷性内頚動脈海綿静脈洞瘻による静脈環流障害から非けいれん性てんかん重積をきたした一例, 第45回日本脳神経外傷学会, Feb. 2022.
40.	Izumi Yamaguchi, Yasuhisa Kanematsu, Kenji Shimada, Nobuaki Yamamoto, Shu Sogabe, Takeshi Miyamoto, Manabu Ishihara, Yuki Yamamoto and Yasushi Takagi : 開頭下にLabbe静脈を直線穿刺することで治療し得たTSS d-AVFの1例, 近畿脳神経血管内手術法ワークショップ, Jan. 2022.
41.	Izumi Yamaguchi, Yasuhisa Kanematsu, Kenji Shimada, Nobuaki Yamamoto, Shu Sogabe, Takeshi Miyamoto, Manabu Ishihara, Yuki Yamamoto and Yasushi Takagi : Trans-vein of Labbe approach for direct embolization of TSS d-AVF, 第92回日本脳神経外科学会中国四国支部会, Dec. 2021.
42.	Shu Sogabe, Yasuhisa Kanematsu, Izumi Yamaguchi, Eiji Shikata, Takeshi Miyamoto, Kenji Shimada, Yuki Yamamoto, Nobuaki Yamamoto and Yasushi Takagi : Initial results of CAS with overlapped open-cell and closed-cell stent at one time, 日本脳神経血管内治療学会, Nov. 2021.
43.	Takeshi Miyamoto, Shu Sogabe, Yasuhisa Kanematsu, Eiji Shikata, Izumi Yamaguchi, Manabu Ishihara, Kenji Shimada, Yuki Yamamoto, Nobuaki Yamamoto, Yuishin Izumi and Yasushi Takagi : Characteristics of ribbon sign in MRI after revascularization in acute ischemic stroke, 日本脳神経血管内治療学会, Nov. 2021.
44.	Yasuhisa Kanematsu, Yuki Kanazawa, Kenji Shimada, Shu Sogabe, Takeshi Miyamoto, Manabu Ishihara, Eiji Shikata, Izumi Yamaguchi, Yoshiteru Tada, Yuki Yamamoto, Nobuaki Yamamoto, Masafumi Harada and Yasushi Takagi : CEST MRIを用いた頚動脈プラーク診断 Chemical exchange saturation transfer MRI for carotid plaque imaging, NMC Case Report Journal, Oct. 2021.
45.	Kenji Shimada, Kazuhisa Miyake, Izumi Yamaguchi, Takeshi Miyamoto, Shu Sogabe, Yasuhisa Kanematsu and Yasushi Takagi : AVM摘出術における3D multimodal fusion imageとICG動注による術中videoangiography併用の有用性, NMC Case Report Journal, Oct. 2021.
46.	Takeshi Miyamoto, Izumi Yamaguchi, Eiji Shikata, Manabu Ishihara, Shu Sogabe, Kenji Shimada, Yasuhisa Kanematsu and Yasushi Takagi : 閉塞性血管障害に対する血行再建術後におけるArterial spin-labelingの変化, NMC Case Report Journal, Oct. 2021.
47.	Shu Sogabe, Yasuhisa Kanematsu, Izumi Yamaguchi, Takeshi Miyamoto, Kenji Shimada, Yuki Yamamoto, Nobuaki Yamamoto and Yasushi Takagi : Results of CAS with overlapped open-cell and closed-cell stent in our hospital, NMC Case Report Journal, Oct. 2021.
48.	Izumi Yamaguchi, Yasuhisa Kanematsu, Kenji Shimada, Nobuaki Yamamoto, Takeshi Miyamoto, Shu Sogabe, Manabu Ishihara, Yuki Yamamoto and Yasushi Takagi : 硬膜動静脈瘻の診断におけるArterial spin-labelingの有用性の検討 Usefulness of Arterial Spin-Labeling for diagnosis of dural arteriovenous fistulae, 日本脳神経外科学会第80回学術総会, Oct. 2021.
49.	Nobuaki Yamamoto, Yuki Yamamoto, KURODA Kazutaka, Izumi Yamaguchi, Shu Sogabe, Kenji Shimada, Yasuhisa Kanematsu, Yuishin Izumi and Yasushi Takagi : 脳主幹動脈閉塞における有効再開通が得られた患者における予後関連因子, 第23回中国四国脳卒中研究会, Sep. 2021.
50.	Yuki Yamamoto, Nobuaki Yamamoto, KURODA Kazutaka, Izumi Yamaguchi, Takeshi Miyamoto, Kenji Shimada, Yasushi Takagi and Yuishin Izumi : 血栓回収療法におけるFirst Pass Effect達成を予測する画像因子の探索, 第62回日本神経学会学術大会, May 2021.
51.	Kenji Shimada, 山本陽子, Izumi Yamaguchi, Takeshi Miyamoto, Shu Sogabe, Yasuhisa Kanematsu and Yasushi Takagi : AVM摘出術におけるHybrid手術室でのインドシアニン・グリーン動注による術中videoangiographyの有用性, 第44回日本脳神経Cl学会総会, Apr. 2021.
52.	Kenji Shimada, Izumi Yamaguchi, Takeshi Miyamoto, Shu Sogabe, 花岡真実, Yasuhisa Kanematsu, Kazuhito Matsuzaki, Koichi Satoh and Yasushi Takagi : 海綿静脈洞部硬膜動静脈瘻におけるshunted pouchと頭蓋底骨の関係, 第46回日本脳卒中学会学術集会, Mar. 2021.
53.	Yasuhisa Kanematsu, Kenji Shimada, Shu Sogabe, Takeshi Miyamoto, Manabu Ishihara, Izumi Yamaguchi, Yuki Yamamoto, Nobuaki Yamamoto and Yasushi Takagi : Treatment outcome of giant thrombosed cerebral aneurysm - Single center study -, 第46回日本脳卒中学会学術集会, Mar. 2021.
54.	Takeshi Miyamoto, Shu Sogabe, Yasuhisa Kanematsu, Kenji Shimada, Izumi Yamaguchi, Nobuaki Yamamoto, Yuki Yamamoto, Yuishin Izumi and Yasushi Takagi : Characteristics of early ribbon sign in MRI after revascularization in acute ischemic stroke, 第46回日本脳卒中学会学術集会, Mar. 2021.
55.	柿原紋太, 野崎夏江, 兼本ひろみ, Megumi Tsuda, Yasuyo Yamamoto, Yuki Yamamoto, Nobuaki Yamamoto, Manabu Ishihara, Kenji Shimada, Yasuhisa Kanematsu, Kyoko Nishi, Shinsuke Katoh and Yasushi Takagi : 徳島大学病院脳卒中センター(SCU)における排尿ケアチーム介入後の下部尿路機能障害の現状, 第45回日本脳卒中学会総会(web開催), Aug. 2020.
56.	Toshitaka Fujihara, Yoshiteru Tada, Kenji Shimada, Yasuhisa Kanematsu and Yasushi Takagi : 内頚動脈海綿静脈洞瘻に急性症候発作重積を合併した1例, 第14回日本てんかん学会中国・四国地方会, Feb. 2020.
57.	石原学, Yasuhisa Kanematsu, Nobuaki Yamamoto, Shu Sogabe, Takeshi Miyamoto, Kenji Shimada, Yuki Yamamoto, Jun Oto and Yasushi Takagi : NIHSS5点以下軽症脳主幹動脈閉塞症例における転帰, 第25回日本脳神経外科救急学会, Feb. 2020.
58.	山本陽子, Yasuhisa Kanematsu, Shu Sogabe, Takeshi Miyamoto, Masaaki Korai, Kenji Shimada and Yasushi Takagi : Neckからfetal typeのPcomが起始する大型血栓化IC-PC動脈瘤に対しステント併用下コイル塞栓術を行った一例, 第88回(一社)日本脳神経外科学会中国四国支部学術集会, Dec. 2019.
59.	Tadashi Yamaguchi, Takeshi Miyamoto, 北里慶子, Eiji Shikata, Izumi Yamaguchi, Masaaki Korai, Kenji Shimada, Yoshiteru Tada, Yasuhisa Kanematsu and Yasushi Takagi : エストロゲン欠乏脳動脈瘤ラットモデルにおけるERαの低下とNLRP3 inflammasome活性の関係, 第62回日本脳循環代謝学会学術集会, Nov. 2019.
60.	Yuki Yamamoto, Nobuaki Yamamoto, Yasuhisa Kanematsu, Manabu Ishihara, Takeshi Miyamoto, Masaaki Korai, Kenji Shimada, Hideo Mure, Yasushi Takagi and Yuishin Izumi : 転倒後の脳脊髄液減少症に上矢状静脈洞血栓症を合併し, 血管内治療をおこなった一例, 第35回日本脳神経血管内治療学会学術総会, Nov. 2019.
61.	Kenji Shimada, Koichi Satoh, Taku Matsuda, Takeshi Miyamoto, Masaaki Korai, Yasuhisa Kanematsu and Yasushi Takagi : Targeting‌embolizationを行わず，流出路をコイル塞栓することにより舌下神経障害なく治療し得た‌ACC‌dAVFの1例, 第35回日本脳神経血管内治療学会学術総会, Nov. 2019.
62.	Yasuhisa Kanematsu, Kenji Shimada, Masaaki Korai, Takeshi Miyamoto, Yoshiteru Tada, Yuki Yamamoto, Nobuaki Yamamoto, Junichiro Satomi and Yasushi Takagi : 当院での急性期脳底動脈閉塞に対する血管内治療成績, 第35回日本脳神経血管内治療学会学術総会, Nov. 2019.
63.	Taku Matsuda, Kenji Shimada, Takeshi Miyamoto, Takashi Abe, Masaaki Korai, Yasuhisa Kanematsu and Yasushi Takagi : T1-CUBEが有効であった頭蓋内動脈解離の2例, 日本脳神経外科学会第78回学術集会, Oct. 2019.
64.	Manabu Ishihara, Yasuhisa Kanematsu, Nobuaki Yamamoto, Takeshi Miyamoto, Masaaki Korai, Kenji Shimada, Yuki Yamamoto, Jun Oto and Yasushi Takagi : NIHSS 5点以下の軽症脳主幹動脈閉塞症例における予後因子, 日本脳神経外科学会第78回学術集会, Oct. 2019.
65.	Tadashi Yamaguchi, Takeshi Miyamoto, 北里慶子, Eiji Shikata, Idumi Yamaguchi, Masaaki Korai, Kenji Shimada, Yoshiteru Tada, Yasuhisa Kanematsu and Yasushi Takagi : 脳動脈瘤破裂モデルにおける部位特異的な早期形態変化と血管崩壊関連分子の変動, 日本脳神経外科学会第78回学術集会, Oct. 2019.
66.	Yasuhisa Kanematsu, Kenji Shimada, Masaaki Korai, Takeshi Miyamoto, Idumi Yamaguchi, Tadashi Yamaguchi, Yoshiteru Tada, Junichiro Satomi, Shinji Nagahiro and Yasushi Takagi : 当院における急性期脳底動脈閉塞に対する治療成績, 日本脳神経外科学会第78回学術集会, Oct. 2019.
67.	Takeshi Miyamoto, 北里慶子, Yoshiteru Tada, Kenji Shimada, Masaaki Korai, Tadashi Yamaguchi, Yasuhisa Kanematsu and Yasushi Takagi : Porphyromonas gingivalis LPSは脳動脈瘤モデルラットにおいて脳動脈瘤破裂を促進する, 日本脳神経外科学会第78回学術集会, Oct. 2019.
68.	Idumi Yamaguchi, Yasuhisa Kanematsu, Kenji Shimada, Masaaki Korai, Takeshi Miyamoto, 北里慶子, Nobuaki Yamamoto, 山本雄貴 and Yasushi Takagi : Retrospective analysis of risk factor associated with worse outcome of in-hospital ischemic stroke, Neurologia Medico-Chirurgica, Oct. 2019.
69.	Nobuaki Yamamoto, Yuki Yamamoto, Manabu Ishihara, Takeshi Miyamoto, Kenji Shimada, Yasuhisa Kanematsu, Yuishin Izumi and Yasushi Takagi : 血行再建術前における経静脈的造影剤投与によるFlat panel CTAの有用性, 中四国脳卒中研究会, Sep. 2019.
70.	Nobuaki Yamamoto, Kazutaka Kuroda, Yuki Yamamoto, Manabu Ishihara, Masaaki Korai, Kenji Shimada, Yasuhisa Kanematsu, Yuishin Izumi and Yasushi Takagi : Tandem Occlusion患者に対する血管内治療(Simultaneous Approach), 第44回日本脳卒中学会学術集会, Mar. 2019.
71.	Yuki Yamamoto, Nobuaki Yamamoto, Kazutaka Kuroda, Masaaki Korai, Toshiyuki Okazaki, Kenji Shimada, Yasuhisa Kanematsu, Yuishin Izumi and Yasushi Takagi : 血栓回収療法後の造影剤腎症は白血球数高値と関連する, 第44回日本脳卒中学会学術集会, Mar. 2019.
72.	Kyoko Nishi, Yasuhisa Kanematsu, Masaaki Korai, Toshiyuki Okazaki, Kenji Shimada, Nobuaki Yamamoto, Hideyuki Takano, Shinsuke Katoh and Yasushi Takagi : 徳島大学病院脳卒中センター (SCU)の多職種連携による医療人育成, 日本脳卒中学会2019, Mar. 2019.
73.	Yuki Yamamoto, Nobuaki Yamamoto, Kazutaka Kuroda, 福本竜也, Manabu Ishihara, Masaaki Korai, Kenji Shimada, Yasuhisa Kanematsu, Yuishin Izumi and Yasushi Takagi : 治療後に症状増悪した上矢状静脈洞血栓症の一例, 第8回脳血管内治療四国遍路塾, Mar. 2019.
74.	Yuki Yamamoto, Kazutaka Kuroda, Nobuaki Yamamoto, Hiroshi Kagusa, Masaaki Korai, Kenji Shimada, Yasuhisa Kanematsu, Yuishin Izumi and Yasushi Takagi : 頭癌治療中に内頚動脈閉塞を認めた1例, 第21回徳島脳血管障害カンファレンス, Mar. 2019.
75.	Yuki Yamamoto, Nobuaki Yamamoto, Kazutaka Kuroda, Masaaki Korai, Toshiyuki Okazaki, Kenji Shimada, Yasuhisa Kanematsu, Yuishin Izumi and Yasushi Takagi : 塞栓回収療法後の造影剤腎症についての検討, 第21回徳島脳卒中研究会, Feb. 2019.
76.	Masaaki Korai, Junichiro Satomi, Yuki Yamamoto, Nobuaki Yamamoto, Toshiyuki Okazaki, Kenji Shimada, Yasuhisa Kanematsu and Yasushi Takagi : Borden type 1横・S状静脈洞部硬膜動静脈瘻に対するバルーン支援下選択的経静脈塞栓術, 第34回日本脳神経血管内治療学会学術総会, Nov. 2018.
77.	Kenji Shimada, 大谷誠, Yasuhisa Kanematsu and Yasushi Takagi : DPCを用いた疫学的調査による我が国の硬膜動静脈瘻の現状, 第34回日本脳神経血管内治療学会学術総会, Nov. 2018.
78.	Kenji Shimada, 佐藤裕一, 羽星辰哉, 花岡真実, 仁木均, Kazuhito Matsuzaki, Koichi Satoh, 三宅一 and Yasushi Takagi : 急性期脳梗塞に対するstent retrieverと吸引カテーテルを併用した血栓回収療法―従来の治療法との比較検討―, 日本脳神経外科学会第77回学術総会, Oct. 2018.
79.	Masaaki Korai, Junichiro Satomi, Yasuhisa Kanematsu, Hideo Mure, Kenji Shimada, Toshiyuki Okazaki and Yasushi Takagi : 硬膜動静脈瘻に対する直達術, 日本脳神経外科学会第77回学術総会, Oct. 2018.
80.	Yasuhisa Kanematsu, Kenji Shimada, Masaaki Korai, Toshiyuki Okazaki, Yoshiteru Tada, Junichiro Satomi, Shinji Nagahiro and Yasushi Takagi : 当院における高齢者(80歳以上)くも膜下出血の治療成績と予後の検討, 日本脳神経外科学会第77回学術総会, Oct. 2018.
81.	Toshiyuki Okazaki, Yasuhisa Kanematsu, Kenji Shimada, Masaaki Korai, Junichiro Satomi, Masaaki Uno and Yasushi Takagi : 当院におけるhemashield patchを使用した頸動脈内膜剥離術の長期成績の検討, 日本脳神経外科学会第77回学術総会, Oct. 2018.
82.	Masaaki Korai, 羽星辰哉, Yuki Yamamoto, Nobuaki Yamamoto, Toshiyuki Okazaki, Kenji Shimada, Yasuhisa Kanematsu and Yasushi Takagi : 脳腫瘍との鑑別を要した海綿静脈胴部硬膜動静脈瘻の一例, 脳血管内治療ブラッシュアップセミナー2018, Sep. 2018.
83.	Takeshi Miyamoto, 山口真司, K.Kung David, 北里慶子, Yoshiteru Tada, Kenji Shimada, Kenji Yagi, Masaaki Korai, Yasuhisa Kanematsu, Junichiro Satomi and Shinji Nagahiro : 新規脳動脈瘤破裂モデルにおける破裂動脈瘤の病態解明, 第59回日本脳循環代謝学会学術集会, Nov. 2016.
84.	Masaaki Korai, 北里慶子, Yoshiteru Tada, Takeshi Miyamoto, Kenji Shimada, Kenji Yagi, Nobuhisa Matsushita, Yasuhisa Kanematsu, Junichiro Satomi and Shinji Nagahiro : メチオニン過剰摂取による高ホモシステイン血症は崩壊しやすい特定脳動脈壁の炎症反応を増強し脳動脈瘤破裂を促進する, 第59回日本脳循環代謝学会学術集会, Nov. 2016.
85.	宮本健志, Kung K David, 北里慶子, 前川秀継, Kenji Yagi, Kenji Shimada, Yoshiteru Tada, Yoshitaka Kurashiki, 吉岡正太郎, Kazuyuki Kuwayama, Junichiro Satomi and Shinji Nagahiro : ラット脳動脈瘤モデルにおける脳動脈瘤増大・破裂に及ぼす血行力学的負荷の影響, 第27回日本脳循環代謝学会, Oct. 2015.
86.	Yoshitaka Kurashiki, 北里慶子, Yoshiteru Tada, Kenji Yagi, Manabu Sumiyoshi, 宮本健志, Kazuyuki Kuwayama, Junichiro Satomi, Kenji Shimada, Tomoya Kinouchi, Yoshihiro Uto and Shinji Nagahiro : 脳虚血後後期におけるGcMAF投与はM2 macrophageを増加させ神経再生に寄与する, 一般社団法人日本脳神経外科学会第74回学術総会, Oct. 2015.
87.	宮本健志, 北里慶子, 前川秀継, Kenji Yagi, Kenji Shimada, Yoshiteru Tada, Yoshitaka Kurashiki, 吉岡正太郎, Kazuyuki Kuwayama, Junichiro Satomi, Shinji Nagahiro and K.Kung David : ラット脳動脈瘤モデルにおける脳動脈瘤増大・破裂に及ぼす血行力学的負荷の影響, 一般社団法人日本脳神経外科学会第74回学術総会, Oct. 2015.
88.	Yoshiteru Tada, Kenji Yagi, 北里慶子, Kazuyuki Kuwayama, Kenji Shimada, Junichiro Satomi, Shinji Nagahiro and 宇野昌明 : 脳血管障害の既住がある高血圧症例に対するオルメサルタンの降圧効果と臓器保護作用, 一般社団法人日本脳神経外科学会第74回学術総会, Oct. 2015.
89.	Hideo Mure, Kenji Yagi, Shinji Nagahiro, Kenji Shimada and Kousaku Higashino : 引き抜き損傷後17年後に発症した脊髄くも膜嚢胞の一例, 第30回日本脊髄外科学会, Jun. 2015.
90.	Manabu Sumiyoshi, Junichiro Satomi, 北里慶子, 鈴江涼子, Kenji Yagi, Kenji Shimada, Yoshiteru Tada, Kazuyuki Kuwayama and Shinji Nagahiro : 脳梗塞におけるHigh mobility group box-1シグナル活性化とエイコサペントエン酸による脳保護作用, 第2回日本心血管脳卒中学会学術集会, Jun. 2015.
91.	Yoshitaka Kurashiki, 北里慶子, Kenji Shimada, Kenji Yagi, Yoshiteru Tada, Tomoya Kinouchi, Manabu Sumiyoshi, Takeshi Miyamoto, Kazuyuki Kuwayama, Junichiro Satomi, Shinji Nagahiro and Yoshihiro Uto : 脳虚血後後期におけるGroup-specific protein-derived macrophage activating factor (GcMAF)投与は，M2 macrophage, 第2回日本心血管脳卒中学会学術集会, Jun. 2015.
92.	宮本健志, Masaaki Korai, 北里慶子, Kenji Shimada, Kenji Yagi, Yoshiteru Tada, Yoshitaka Kurashiki, Junichiro Satomi, Shinji Nagahiro and Kung K David : ラットモデルにおける血行力学的変化と脳動脈瘤形成および破裂の関係, 第26回日本脳循環代謝学会, Nov. 2014.
93.	Teruyoshi Kageji, Yoshitaka Kurashiki, 北里慶子, Kenji Shimada, Kenji Yagi, Yoshiteru Tada, Tomoya Kinouchi, Manabu Sumiyoshi, 宮本健志, Junichiro Satomi, 宇都義弘 and Shinji Nagahiro : 虚血後後期におけ脳るGroup-specific protein-derived macrophage activating factor(GcMAF)によるM2 macrophage, 第26回日本脳循環代謝学会, Nov. 2014.
94.	Tomoya Kinouchi, 北里慶子, Kenji Shimada, Nobuhisa Matsushita, 岡﨑敏之, Manabu Sumiyoshi and Shinji Nagahiro : 卵巣摘出ラットにおけるピオグリタゾンの脳虚血領域での神経再生促進効果について, 第37回日本脳卒中学会総会, Apr. 2012.
95.	Nobuhisa Matsushita, 北里慶子, Kenji Shimada, Yasuhisa Kanematsu, Junichiro Satomi and Shinji Nagahiro : 体内塩分貯留は脳動脈瘤形成の独立した危険因子である, 第37回日本脳卒中学会総会, Apr. 2012.
96.	Nobuhisa Matsushita, 北里慶子, Kenji Shimada, Tomoya Kinouchi, Yasuhisa Kanematsu, Junichiro Satomi and Shinji Nagahiro : 塩分過剰摂取は脳動脈瘤形成増大の独立した危険因子か?, 第36回日本脳卒中学会総会, Jul. 2011.
97.	Tomoya Kinouchi, 北里慶子, Kenji Shimada, Nobuhisa Matsushita, Junichiro Satomi and Shinji Nagahiro : 卵巣摘出ラットにおけるピオグリタゾンのSTAT3を介した脳虚血境界領域での神経保護作用のメカニズム, 第36回日本脳卒中学会総会, Jul. 2011.
98.	Kenji Shimada, 北里慶子, Tomoya Kinouchi, Kenji Yagi, Yoshiteru Tada, Junichiro Satomi, Teruyoshi Kageji and Shinji Nagahiro : オルメサルタンによる脳梗塞抑制効果の新たなメカニズム;estrogen receptor αと脳内のRASの制御, 第36回日本脳卒中学会総会, Jul. 2011.
99.	Kenji Shimada, 北里慶子, Tomoya Kinouchi, Kenji Yagi, Yoshiteru Tada, Junichiro Satomi, Teruyoshi Kageji and Shinji Nagahiro : 卵巣摘出ラットにおけるオルメサルタンの組織RASの抑制を介した脳梗塞の抑制効果について, 第39回日本脳卒中の外科学会, Apr. 2010.
100.	片岡芳規, Kenji Shimada, Hidehisa Horiguchi, Kazuhito Matsuzaki, Teruyoshi Kageji and Shinji Nagahiro : 第3脳室内巨大奇形種の1例, 第21回中国四国脳腫瘍研究会, Sep. 2007.
101.	Kazuhito Matsuzaki, 友金祐介, Kenji Shimada, Hideo Mure, Tetsuya Tamura, Hidehisa Horiguchi, Teruyoshi Kageji and Shinji Nagahiro : 定位脳組織生検の診断率と合併症, 第16回脳神経外科手術と機器学会, Apr. 2007.
102.	Yoshiteru Tada, Ryoma Morigaki, Kenji Shimada, Atsuhiko Suzue, Kyoko Nishi, Masaaki Uno and Shinji Nagahiro : 急性期STA-MCA anastomosisの検討, 第36回日本脳卒中の外科学会, Mar. 2007.
103.	Kenji Shimada, Kazuhito Matsuzaki, Teruyoshi Kageji, Shinji Nagahiro and 田代敬 : 初診時髄腔内播腫を認めた成人脈絡叢乳頭腫の1例, 第24回日本脳腫瘍病理学会, Jun. 2006.

Et cetera, Workshop:

1.	鹿草 (名), 松田拓, 石原学, Masaaki Korai, Toshiyuki Okazaki, Kenji Shimada, Yasuhisa Kanematsu and Yasushi Takagi : くも膜下出血で発症した，前方循環系の動脈解離, 第44回徳島脳神経外科談話会, Dec. 2018.
2.	Hideo Mure, Kenji Shimada, Shinji Nagahiro, Kousaku Higashino and Koichi Sairyo : 引き抜き損傷後17年後に発症した脊髄くも膜嚢胞の一例, 第70回近畿脊髄外科研究会, Oct. 2014.
3.	Junichiro Satomi, 羽星辰哉, Kenji Shimada, 曽我部周, Kazuyuki Kuwayama and Shinji Nagahiro : 大型内頚動脈瘤に対するhigh flow bypass，血管内手技を用いた治療戦略, 第19回四国脳神経外科カンファレンス, Aug. 2014.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

脳血管障害に影響を及ぼす特定歯周病菌の同定とその制御法の検討 (Project/Area Number: 23K08500 )
脳動静脈奇形における血管内皮のKRAS変異とPAD4活性化の関係 (Project/Area Number: 22K09259 )
Role of inflammasome activation and sirtuins in cerebral aneurysm rupture (Project/Area Number: 20K09391 )
Effects of exosomes of periodontal lesions on ruptured cerebral aneurysms (Project/Area Number: 20K09326 )
Intracranial aneurysms related to periodontal disease in basic- and clinical studies (Project/Area Number: 17K10832 )
Inflammasome activation induced rupture of intracranial aneurysms (Project/Area Number: 17K10831 )
Search by Researcher Number (60624351)

Associate Professor : Shimada, Kenji

Research

Field of Study

Subject of Study

Book / Paper

Academic Paper (Judged Full Paper):

Academic Paper (Unrefereed Paper):

Proceeding of International Conference:

Proceeding of Domestic Conference:

Et cetera, Workshop:

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)